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ABSTRACT
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder affecting motor
neurons. Cu, Zn superoxide dismutase (SOD1), a cytoplasmic free radical scavenging enzyme, is
mutated in familial ALS (fALS) and post-translational modification of the wild-type protein has
been associated with sporadic ALS (sALS). Proteomic studies indicate that SOD1 is acetylated at
Lys123; however, the role of this modification remains unknown. To investigate its function, we
generated antibodies for Lys123-acetylated SOD1 (Ac-K123 SOD1). Sod1 deletion in Sod1-/mice, K123 mutation, or preabsorption with Ac-K123 peptide suppressed immunoreactivity,
confirming antibody specificity. In the normal central nervous system, Ac-K123 SOD1 maps to
glutamatergic neurons of the cerebellar cortex, dentate gyrus, hippocampus, olfactory bulb,
and retina. In cultured neurons, Ac-K123 SOD1 localized to defined regions of axons and
dendrites. Previous studies have suggested a role for SOD1 in cell cycle regulation. Therefore,
we tested the distribution of Ac-K123 SOD1 during the cell cycle of astrocytes. In G1 Ac-K123
SOD1 localized to the nucleus, in G0 to the primary cilium, in metaphase and anaphase to
chromosomes, and in telophase to the midbody. The deacetylase HDAC6 and acetyl-transferase
α-TAT1 are associated with the primary cilium. Therefore, we tested whether they regulate
reversible acetylation of SOD1. HDAC6 knockdown or pharmacological inhibition markedly
increased, while HDAC6 overexpression decreased, SOD1 Lys123 acetylation. By contrast, SOD1
Lys123 acetylation was decreased by α-TAT1 knockdown and increased by α-TAT1
overexpression. These results suggest that HDAC6 and α-TAT1 regulate SOD1 Lys123
acetylation. Next, we examined Lys123 acetylation in fALS SOD1 mutants. Remarkably, Lys123
iii

acetylation was dramatically increased in fALS mutants including SOD1 A4V. The acetyl-Lys123
mimetic of wild-type SOD1 caused axonal transport deficits similar to those observed in SOD1
pathogenic mutants such as A4V. Interestingly, HDAC6 deacetylation or acetylation resistance
by Lys123 mutation, abolished A4V protein misfolding, axonal transport defects, and neuronal
cell death. These results suggest that Lys123 acetylation plays a key role in the neurotoxicity of
fALS mutants and may have implications in sALS. Because Ac-K123 SOD1 maps to the primary
cilium, we examined whether ciliogenesis is altered in fALS mutant SOD1 astrocytes. Strikingly,
fALS mutants caused centriole and primary cilia proliferation with ciliary ectosome secretion.
Notably, multiciliated ependymal cells in the brain ventricles and spinal cord central canal,
which are critical for cerebral spinal fluid circulation, stained strongly for Ac-K123 SOD1. Thus,
we speculate that ciliary ectosome shedding from ependymal cells accounts for the presence of
misfolded SOD1 in the CSF in fALS and perhaps sALS. In summary, we identified SOD1 Lys123
acetylation as a novel mechanism underlying protein misfolding and neurodegeneration in ALS.
Ac-K123 SOD1 may emerge as novel target for the diagnosis and treatment of ALS.
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CHAPTER ONE: GENERAL REVIEW
1.1 Overview of SOD1
Cu,Zn superoxide dismutase, or superoxide dismutase 1 (SOD1), is a highly conserved and
ubiquitously expressed protein best known for its role in defense against oxidative stress
(Fridovich, 1995). SOD1 is abundant, particularly in the central nervous system where it
comprises 1–2% of the total soluble protein (Pardo et al., 1995). In 1993 a large collaborative
group demonstrated that some inherited forms of amyotrophic lateral sclerosis (ALS), a rapidly
progressive and lethal neurodegenerative disease affecting motor neurons, are caused by
mutations of the human SOD1 gene (Rosen et al., 1993). To date, more than 180 point
mutations in the SOD1 gene have been identified (http://alsod.iop.kcl.ac.uk/).

1.1.1 SOD1 structure
The active SOD1 enzyme is a 32 kDa homodimeric enzyme, consisting of 153 amino acids per
monomer subunit. Each monomer subunit consists of eight anti-parallel strands connected by
three external loops, which after proper folding forms a Greek key β-barrel structural motif
(Getzoff et al., 1989).
Three post-translational modifications are required for SOD1 maturation: intramolecular
disulfide bond formation, dimerization, and copper and zinc acquisition (Kawamata and
Manfredi, 2010). Within each subunit, the intramolecular disulfide bond between C57 and C146
facilitates correct folding and stabilizes the active homodimer (Arnesano et al., 2004). The
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dimer is held together at the dimer interface, a region consisting of the hydrophobic contacts
between subunits (Tainer et al., 1982). Dimerization reduces the solvent accessible surface
area, greatly increasing the stability of SOD1 (Goodsell and Olson, 2000). SOD1 is unstable in its
metal-free and disulfide-reduced forms, but when mature, the protein is highly stable (Khare et
al., 2004). Fully metallated SOD1 has a melting point between 85–95°C, depending on the
buffer, and remains enzymatically active in 8 M urea or 4 M guanidine-HCl (Forman and
Fridovich, 1973; Lepock et al., 1985). This stability is also demonstrated by an extremely long
half-life. A recent in vivo kinetic approach revealed a slow turnover of SOD1 within the CNS,
with the average half-life of SOD1 in the CSF measured at approximately 25 days (Crisp et al.,
2015).
The electrostatic and zinc-binding loops are of great importance to the superoxide scavenging
ability of SOD1. Together these loops form a compact and highly ordered structure around the
active site. Both are coordinated by zinc, an ion essential for overall monomer structure and
dimer stability. The zinc-binding loop supports the dimer interface at the outer surface and
contains the conserved disulfide bond important for dimer stability. The highly specific
dismutase catalysis occurs at the redox-active Cu1+/2+ and depends on electronic guidance of
the superoxide substrate to the active site via charged residues contained within the
electrostatic loop. Dissociation of zinc results in disorganization of the active-site loops, making
the loops more dynamic and increasing non-specific substrate access to the copper ion
(Sahawneh et al., 2010).
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1.1.2 SOD1 function
Superoxide dismutase 1 (SOD1) is an enzyme whose canonical role is to protect the cell against
oxidative damage by reactive oxygen species (ROS). These highly reactive, free radicalharboring molecules, produced by mitochondria as a byproduct of cellular respiration (Muller
et al., 2004), result in cumulative damage that includes DNA mutations and deletions, lipid
peroxidation, oxidation of amino acids in proteins, and inactivation of enzymes by oxidation of
co-factors. In its role as an antioxidant, SOD1 metabolizes two superoxide radicals to molecular
oxygen and hydrogen peroxide (McCord and Fridovich, 1969). Using copper at its active site,
SOD1 catalyzes a disproportionation reaction where one superoxide molecule is oxidized and
another molecule is reduced in what can described as a ‘ping-pong’ mechanism (Figure 1).

Figure 1. SOD1 and the superoxide dismutase reaction.
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Other SOD1 functions include copper buffering, zinc homeostasis, phosphate activation, and
protein nitration (Beckman et al., 1993; Culotta et al., 1997; Wang et al., 1996; Wei et al., 2001).
A more recently described role involves metabolic state signaling, where SOD1 integrates
signals from oxygen and glucose in order to modulate respiration within cells through casein
kinase signaling (Reddi and Culotta, 2013). Additional cellular functions of SOD1 include RNA
binding and transcriptional regulation in response to oxidative stress (Tsang et al., 2014;
Volkening et al., 2009). Furthermore, studies have shown that only a small amount of the total
SOD1 within cells (less than 1%) is actually required to prevent toxicity from superoxide (Corson
et al., 1998). As SOD1 is produced at high levels in many organisms, this hints at other as-of-yet
undetermined functions.

1.1.3 SOD1 subcellular localization
SOD1 is primarily a cytosolic protein, but is also found within the nucleus, lysozymes,
peroxisomes, and mitochondrial inner membrane space (Chang et al., 1988; Crapo et al., 1992;
Keller et al., 1991; Sturtz et al., 2001).

1.1.4 SOD1 post-translational modifications
SOD1 post-translational modification (PTM) by phosphorylation, palmitoylation, sumoylation,
succinlyation, and glutathionylation has been described (Antinone et al., 2013; Lin et al., 2013;
Redler et al., 2011). Proteomics studies have also identified acetylation at conserved lysine 123
(K123), located within the electrostatic loop, in human, mouse, and rat SOD1 (Choudhary et al.,
4

2009; Lundby et al., 2012; Weinert et al., 2013; Yang et al., 2011; Zhao et al., 2010) (Figure 2AB). Sequence alignment demonstrates that Lys123 and surrounding sequences are highly
conserved across many species, suggesting an essential (yet uncharacterized) regulatory
function (Figure 2C). SOD1 PTM can alter enzymatic efficiency, induce monomer formation, and
promote aggregation and cell death (Wilcox et al., 2009). SOD1 K123 is located at the mouth of
the electrostatic loop and within close proximity to the copper-containing active site. K123
acetylation may cause slight perturbations of the electrostatic loop that allow non-specific
substrates to enter the active site. This can cause aberrant redox chemistry and possibly
reverse catalysis which results in the production of superoxide. For these reasons it is important
to gain a better understanding of Lys123 acetylation and any impact this PTM may have on
SOD1 structure and function.

5

Figure 2. SOD1 is acetylated at conserved Lysine 123
A. Domain graph of SOD1 depicting acetylation at Lys123. Graph was created from the SOD1
amino acid sequence and referenced metal binding sites located on Uniprot (ID: P00441) using
Domain Graph 2.0. B. Lys123 is located within the electrostatic loop, a functional domain
important for superoxide substrate recruitment into the active site of SOD1. Modeling was
done by A. Kennedy with Pymol 1.3 utilizing a SOD1 structure located on the Research Colaboratory for Structural Bioinformatics Protein Data Bank (RSCB PDB) using the ID, 2V0A. The
6

structure is represented in ribbon format while the metal binding sites are represented in stick
format. C. Lys123 (highlighted in red) is highly conserved among many species. All sequences
are isoform 1 of their respective species and were obtained from Uniport. BLAST sequence
alignment by A. Kennedy. Sequences were copied into Cobalt to generate a multiple protein
alignment. The sequence was then exported from Cobalt into ClustalX 2.0 using Clustal
formatting option.

1.2 Protein Acetylation
1.2.1 Overview of lysine acetylation
PTMs allow cells to rapidly respond to changes in the external and internal microenvironment.
Perhaps the most intensively studied PTM is phosphorylation, which occurs at approximately
24,000 known sites on more than 8,000 proteins (Gnad et al., 2011). However, phosphorylation
is not the only major protein modification that is under enzymatic regulation. Proteins are also
commonly modified by methylation, SUMOylation, ubiquitination, and acetylation.
During acetylation, the functional acetyl group from acetyl coenzyme A (Ac-CoA) is transferred
to proteins. Catalyzed by N-terminal acetyltransferases, acetylation occurs co-translationally at
the α-amino group of the N-terminus in the vast majority of proteins (Figure 3A) (Arnesen et al.,
2009). Acetylation can also occur post-translationally at the ε-amino group of lysine residues
(Figure 3B). Unlike acetylation of the N-terminus, lysine acetylation is a reversible and tightly
regulated process.
Lysine acetylation is catalyzed by lysine acetyltransferases (KATs), while the deacetylation of
lysine is catalyzed by lysine deacetylases (KDACs). It should be noted that KATs and KDACs are
also more commonly referred to as histone acetyltransferases (HATs) and histone deacetylases
7

(HDACs) for historical reasons, as acetylated lysine residues were first discovered in histones,
the proteins within eukaryotic cell nuclei that packages DNA into chromatin (Allfrey et al.,
1964). However, we now know that numerous other nuclear and non-nuclear proteins are
modified by lysine acetylation (Glozak et al., 2005). To date, proteomic studies have identified
more than 15,000 lysine acetylation sites on 4,541 proteins (Choudhary et al., 2009; Lundby et
al., 2012).

Figure 3. Schematic overview of protein acetylation.
A. The enzymatic transfer of an acetyl group from acetyl-CoA to the N-terminal α-amino group
of a polypeptide. The irreversible reaction is catalyzed by N-terminal acetyltransferases (NATs).
B. The reversible acetylation of the ε-amino group of a lysine residue is catalyzed by lysine
acetyltransferases (KATs), whereas lysine deacetylases (KDACs) catalyze the deacetylation of
lysine residues.
8

The 22 identified KATs are grouped into three major families: the GNAT family, the MYST
family, and the p300/CBP (CREB-binding protein) family (Allis et al., 2007). Most KATs form
multiprotein complexes with various subunits, with the catalytic activity and substrate
specificity of the KAT largely dependent on the context of the other subunits in the complex
(Lee and Workman, 2007).
KDACs comprise a family of 18 enzymes that play diverse roles in mammalian cell homeostasis.
The 18 KDAC isoforms are grouped into four classes based on sequence homology of the
catalytic domain to yeast deacetylases. The isoforms within Class I (HDAC1, 2, 3 and 8), Class II
(HDAC4, 5, 6, 7, 9, and 10), and Class IV (HDAC11) are all zinc-dependent amidohydrolases.
They possess a zinc-binding domain at the active site, which is required for enzymatic activity.
The final seven isoforms belong to Class III and are referred to as silent information regulator 2
(Sir2) proteins, or more commonly the sirtuins (Sirt1–7). They differ from the other HDAC
classes in that their enzymatic activity is dependent on the use of NAD+ as a co-substrate. In
addition, some of the sirtuins exhibit localization to mitochondria where they regulate various
metabolic processes (Verdin et al., 2010).

1.2.2 Functional effects of lysine acetylation
Reversible acetylation plays an important role in regulating the structure, function, and
interaction of proteins. The functional effects of lysine acetylation were first described for
histones, where acetylation stimulates transcription by remodeling chromatin, weakening
histone-DNA interactions, and providing binding sites for transcription factors (Bannister and
9

Kouzarides, 1996; Mizzen et al., 1996; Ogryzko et al., 1996; Parthun et al., 1996; Taunton et al.,
1996).
Acetylation has also been examined in a growing number of non-histone proteins, where it may
induce conformational change and steric hindrance. This can potentially affect the catalytic
activity, stability, protein-protein interactions, and subcellular localization and targeting of
many proteins (Kouzarides, 2000; Zhao et al., 2010). Consequently, the functional effects of
lysine acetylation are wide ranging and encompass diverse biological processes. Cellular
processes regulated by acetylation include cell cycle, nucleic acid splicing, subcellular
localization and transport, and mitochondrial function and metabolism. At the level of the
organism, acetylation plays important roles in immunity, circadian rhythmicity, and memory
formation (Haberland et al., 2009). Dysregulation of lysine acetylation has been reported in
numerous disorders including neurodegeneration, cancer, and cardiovascular disorders, making
protein acetylation a favorable target in drug design (Drazic et al., 2016).
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CHAPTER TWO: SOD1 ACETYLATION IN THE NORMAL CNS
2.1 SOD1 in the CNS
The central nervous system is highly prone to toxicity from ROS. This susceptibility stems from
high oxygen consumption and a relatively poor antioxidant defense (Aksenov et al., 1998; Slivka
et al., 1987). SOD1 is an abundant protein that is ubiquitously expressed in the central nervous
system (Pardo et al., 1995). The development of age-related neuromuscular and neuronal
abnormalities in Sod1 knockout (Sod1 -/-) mice underscores the importance of SOD1 protein in
the central nervous system.

2.1.1 SOD1 knockout mice
SOD1 deficiency renders mice more sensitive to oxidative stress and results in many different
phenotypes that resemble accelerated aging. Sod1 -/- mice do not exhibit abnormalities during
development and early adulthood, but they have reduced lifespan and evidence of various
oxidative stress markers, including a markedly increased incidence of liver cancer (Elchuri et al.,
2004). 1
Within the nervous system, SOD1 deficiency results in a wide range of phenotypes (Saccon et
al., 2013). Sod1 -/- mice are prone to early vision loss due to the development of progressive
retinal cell degeneration and age-related macular degeneration (Hashizume et al., 2008;

This chapter includes material from the article “SOD1 Lysine 123 Acetylation in the Adult Central Nervous System”
accepted for publication in Frontiers in Cellular Neuroscience by Frontiers Media SA
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Imamura et al., 2006). Within the cochleae of the inner ear, the absence of SOD1 causes hair
cell degeneration and decreased spiral ganglion cell density, resulting in a progressive hearing
loss (Keithley et al., 2005). Adult-onset progressive motor axonopathy is observed in Sod1 -/mice, demonstrated by a slowly progressive motor deficit and decreased repair after axonal
injury (Fischer et al., 2012; Flood et al., 1999; Larkin et al., 2011). Sod1 -/- mice are more
susceptible to brain damage following cerebral ischemia, in part due to increased disruption of
the blood-brain-barrier (Kim et al., 2003; Kondo et al., 1997). Following traumatic brain injury,
Sod1-/- mice exhibit increased damage (Lewén et al., 2000), further signifying a protective role
of SOD1 in the CNS. SOD1 deficiency results in increased susceptibility to neurodegeneration,
demonstrated by exacerbated memory loss, tau phosphorylation, amyloid beta (Aβ)
oligomerization, and plaque deposition in the double mutant progeny of Sod1 -/- mice crossed
to a mouse model of Alzheimer’s disease (Murakami et al., 2011, 2012). Furthermore, there is a
link between SOD1 deficiency and Fragile X syndrome, the most frequent form of inherited
mental retardation. Interestingly, the RNA-binding protein Fragile X Mental Retardation Protein
(FMRP), whose absence is the cause of Fragile X syndrome, has been shown to increase SOD1
translation through the binding of Sod1 mRNA (Bechara et al., 2009). This suggests that the
reduced level of SOD1 protein observed in Fmrp1 -/- mice plays a role in the physiopathology of
Fragile X syndrome. Taken together, these phenotypes highlight a critical role for SOD1 in the
nervous system.
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Here, we report the generation of new polyclonal rabbit antibodies against the K123-acetylated
form of SOD1 and characterize the distribution of Ac-K123 SOD1 in the normal mouse nervous
system.
2.2 Materials and Methods
2.2.1 Reagents
Kanamycin A monosulfate, phosphate buffered saline, pH 7.4 (PBS), EDTA, Tubastatin A
hydrochloride, gelatin from cold water fish skin 45% in H2O, Ponceau S solution 0.1% w/v and
5% acetic acid, and sodium orthovanadate were obtained from Sigma. Trichostatin A (TSA) was
obtained from Cayman Chemicals. Nicotinamide (NAM) was obtained was from Fluka Chemical.
Fetal bovine serum (FBS), 100x penicillin-streptomycin solution, and Dulbecco’s Modified Eagle
Medium (DMEM) containing 4500 mg/L D-glucose, GlutaMax-1, and 110 mg/L sodium pyruvate
were obtained from Gibco by Life Technologies. Neutralized bacteriological peptone was
obtained from Oxoid. HEPES-free acid, NaCl, and KCl were obtained from OmniPur/Calbiochem.
Sucrose-ultrapure was obtained from J.T. Baker. Tris-proteomic grade, and β-Mercaptoethanolproteomic grade were obtained from AMRESCO. 3-[(3-Cholamidopropyl)dimethylammonio]-1propanesulfonate (CHAPS) was obtained from G-Biosciences. Paraformaldehyde-EM grade, Prill
purified was obtained from Ted Pella, Inc. Optimal Cutting Temperature (OCT) compound,
Tissue-Tek Cryomolds, and Accu-Edge low profile microtome blades were obtained from
Sakura. Isoflurane, USP was obtained from Abbott Laboratories. Tissue Protein Extraction
Reagent (T-PER), 10% Tween-20 Surfact-Amps detergent solution, HALT protease inhibitor
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cocktail, HALT phosphatase inhibitor cocktail, Gene Jet Plasmid Maxiprep kit, TurboFect
transfection reagent, Bolt LDS sample buffer, Bolt Bis-Tris Plus 4-12% gradient polyacrylamide
gels, Bolt MES sodium dodecyl sulfate (SDS) running buffer, Pierce Coomassie Plus Bradford
assay kit, iBlot Gel transfer stacks, iBolt Dry Blotting System, Pierce Western Blotting Substrate,
20 mM Hoechst 33342 solution, Cytoseal 60, and premium cover glass were all obtained from
Thermo Fisher Scientific. The QuikChange Lightning site-directed mutagenesis kit and XL10-Gold
Ultracompetent cells were obtained from Agilent Technologies. PCR primers for site-directed
mutagenesis were obtained from Integrated DNA Technologies. QIAprep Spin Miniprep Kit was
obtained from Qiagen. Difco Luria Bertani broth (LB), Lennox, was obtained from BD. Agar,
yeast extract, and tryptone were obtained from EMD Millipore. Tissue culture dishes (100 and
145 mm) were obtained from Greiner Bio. Costar cell scrapers were obtained from Corning.
cOmplete Mini, EDTA-free protease inhibitors were obtained from Roche. Amersham Hyperfilm
ECL high performance chemiluminescence films were obtained from GE Healthcare Limited.
Histochoice MB Tissue Fixative was obtained from AMRESCO. VECTAShield fluorescent
mounting medium was obtained from Vector Laboratories, Inc. Superfrost Plus slides were
obtained from VWR.

2.2.2 Antibodies
Custom polyclonal rabbit antibodies for Ac-K123 SOD1 were generated by YenZym Antibodies,
LLC, by immunization of two rabbits (R25 and R26) with the peptide VVHE-acK-ADDLGKGGC (AcK123 peptide) of human SOD1119-131 conjugated to the carrier protein THY. Pre-immune serum,
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test serum, and final anti-serum were collected and antibody titers were confirmed by enzymelinked immunosorbent assay (ELISA). Acetylation-specific antibodies were purified from antisera using an affinity matrix conjugated with the acetylated peptide. To eliminate any crossreactive material, the antibody fraction was then further purified using a matrix conjugated
with the unacetylated peptide VVHEKADDLGKGGC (K123 peptide). Purification of the
acetylation-specific antibodies was confirmed using ELISA with the acetylated and unacetylated
peptide.
Commercial mouse monoclonal SOD1 (G-11), rabbit polyclonal SOD1 (FL-154), goat polyclonal
calbindin D28K (N-18), and goat polyclonal doublecortin (C18) antibodies were obtained from
Santa Cruz Biotechnology, Inc. Chicken polyclonal glial fibrillary acidic protein (GFAP) (ab4674)
antibody and rabbit polyclonal beta-III tubulin (ab18207) antibody were obtained from Abcam.
Mouse monoclonal α-tubulin (DM1A) antibody was obtained from Cell Signaling Technology.
Mouse monoclonal NeuN (A60) monoclonal antibody was obtained from EMD Millipore. Mouse
monoclonal acetylated-α-tubulin (6-11B-1) antibody was obtained from Sigma. Rabbit
polyconal SOD1 (rat) (10011387) was obtained from Cayman Chemical.
Secondary peroxidase-conjugated AffiniPure donkey anti-rabbit IgG (H+L), peroxidaseconjugated AffiniPure donkey anti-mouse IgG (H+L), and Alexa Fluor 594 AffiniPure Fab
fragment donkey anti-rabbit IgG (H+L) antibodies were obtained from Jackson
ImmunoResearch Laboratories, Inc. Goat anti-rabbit IRDye 800CW and goat anti-mouse IRDye
680LT antibodies were obtained from LI-COR. Alexa Fluor 488 goat-anti-rabbit IgG (H+L), highly
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cross-absorbed, Alexa Fluor 594 goat anti-mouse IgG (H+L), Alexa Fluor 594-donkey anti-goat
IgG (H+L), and Alexa Fluor 647 donkey-anti-chicken IgG (H+L) were obtained from Molecular
Probes.

2.2.3 Mice and rats
B6;129S-Sod1tm1Leb/J (Sod1 -/+), B6126F1/J, (Sod1+/+), DBA/2J, and129S1/SvlmJ mice
(Jackson Laboratories) were used for immunohistochemical analysis of brains and eyes. Sod1-/mice were generated as previously described (Kondo et al., 1997). Spinal cords were isolated
from CFW mice (Charles River). Timed-pregnant Sprague Dawley rats (Charles River) were used
for the isolation of primary neurons. All experiments were approved by the Institutional Animal
Care and Use Committee of University of Central Florida College of Medicine.

2.2.4 Site-directed mutagenesis
SOD1 K123 nonacetylated mimetic (K123R) was created by site-directed mutagenesis of pEGFPC1 WT SOD1 (gift from Dr. Kurt J. DeVos, University of Sheffield) using the QuikChange Lightning
kit and the following primers:
Table 1. Primers used for mutagenesis of GFP-tagged SOD1 K123.
Primer
K123R Forward
K123R Reverse

Sequence
5’-GCACACTGGTGGTCCATGAAAGAGCAGATGACTTGGGC-3’
5’-GCCCAAGTCATCTGCTCTTTCATGGACCACCAGTGTGC-3’
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Briefly, mutation-containing primers were designed and synthesized (Integrated DNA
Technologies, Coralville, IA) for incorporation into the respective plasmids using linear
amplification followed by digestion of parental DNA with the methylated DNA specific
restriction endonuclease DpnI. XL10-Gold Ultracompetent cells were then transformed with
DpnI-treated DNA via the heat shock method, recovered with Super Optimal Broth (SOB) (0.5%
yeast extract, 2% tryptone, 10 mM NaCl, 2.5 mM KCl, 20 mM MgSO4), and plated onto LB agar
plates containing 100 µg/mL kanamycin A. After 37°C overnight incubation, colonies were
selected from plates and used for inoculation of LB medium containing kanamycin A. Cultures
were grown and used for DNA plasmid extraction via the QIAprep Spin Miniprep Kit per
manufacturer’s instructions. Plasmid sizes were verified by agarose gel electrophoresis,
mutations were confirmed by DNA sequencing (Eurofins Scientific), and larger cultures were
inoculated and grown for large scale endotoxin-free plasmid purification using the Gene Jet
Plasmid Maxiprep kit.

2.2.5 Transfection of human cells
For expression of GFP-tagged recombinant SOD1 WT or K123R in human cells, Turbofect
transfection reagent was added to 10 µg DNA diluted in serum-free DMEM medium. After
incubation at room temperature for 20 minutes, the DNA mix was added to HEK293 cells
seeded on 100 mm tissue culture plates growing at approximately 70% confluency at time of
transfection. Cells were harvested and lysed 72 hours post-transfection for analysis by western
blot.
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2.2.6 Deacetylase inhibitor treatment of human cells
To enhance detection of Ac-K123 SOD1, HEK293 cells were treated for 6 hours with both class
I/II histone deacetylase inhibitor trichostatin A and class III histone deacetylase inhibitor
nicotinamide, or vehicle control. Treated cells were harvested and lysed for analysis by western
blot.

2.2.7 Cell lysate and western blot
Briefly, the cells were placed on ice and the growth medium was aspirated and replaced with 5
mL ice-cold PBS. Cells were removed from the plate using a cell scraper and pelleted by
centrifugation at 100x g for 10 minutes at 4°C in an Eppendorf 5810R table centrifuge. The cell
pellets resuspended in ~500 µL of ice-cold lysis buffer (50 mM HEPES-Na pH 7.4, 150 mM NaCl,
1mM EDTA, 2% CHAPS, 2 mM DTT, 1 mM MgCl2, 1 mM NAM, 1 µM TSA, 2 mM Sodium
Orthovanadate, and cOmplete EDTA-free protease inhibitors). After a 30 minutes incubation on
ice and occasional vortexing, soluble proteins were obtained by centrifugation at 18,200x g for
20 minutes at 4°C in an Eppendorf 5417R microcentrifuge. Supernatants were removed and
protein concentrations were determined using a Pierce BCA protein assay kit. Cell extracts were
mixed with LDS sample buffer and β-mercaptoethanol, boiled for five minutes, and applied to a
Bolt Bis-Tris 4-12% gradient precast polyacrylamide gel for gel electrophoresis using Bolt MES
sodium dodecyl sulfate running buffer. Proteins were next transferred to a nitrocellulose
membrane via the iBlot Dry Blotting System. Transfer efficiency was evaluated by Ponceau S
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staining of transferred membrane, followed by washes with ddH2O and blocking with 5%
bacteriological peptone /1% fish gelatin in Tris-buffered saline containing 0.1% Tween-20 (TBST)
overnight at 4°C. Membranes were then washed with TBST followed by 4°C overnight
incubation with anti-Ac-K123 SOD1 antibody (1 µg/mL) and anti-SOD1 clone G11 monoclonal
antibody (1:5,000). Incubation with anti-α-Tubulin clone DM1A monoclonal antibody (1:2,500)
was performed as a loading control. Following primary antibody incubations, membranes were
washed with TBST and incubated with donkey anti-rabbit or donkey anti-mouse horseradish
peroxidase-conjugated secondary antibodies (1:20,000) for 1 hour at room temperature.
Membranes were then washed with TBST, rinsed once in TBS, and visualized with enhanced
chemiluminescence after application of Pierce ECL Western Blotting Substrate.

2.2.8 Tissue Preparation
Brains and eyes were collected from 5-month-old male mice, with at least 3 separate mice from
both DBA/2J and 129S1/SvlmJ strains (Jackson Laboratory, Bar Harbor, ME). Spinal cords were
isolated from three CFW mice, aged 4 months (Charles River Laboratories, Wilmington, MA). All
mouse experiments were performed in accordance with guidelines set by the Institutional
Animal Care and Use Committee of the University of Central Florida. To isolate retinas,
129S1/SvlmJ mice were sacrificed by a lethal dose of isoflurane. Eyes were removed and radial
cuts were made in the cornea to remove the lens. The isolated eye cups were then fixed in 4%
paraformaldehyde, 5% sucrose, in PBS, for 15 minutes at room temperature. Retinas were then
isolated and fixed for an additional 45 minutes in 4% paraformaldehyde, 5% sucrose, in PBS.
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After fixation, the retinas were rinsed 3x for 10 minutes with 5% sucrose in PBS. For
cryoprotection, the retinas were incubated for 30 minutes with 5% and then 10% sucrose in
PBS. Finally, the retinas were kept in 20% sucrose in PBS overnight at 4 o C. For embedding,
retinas were incubated for 30 minutes in 100% OCT, followed by 30 minutes in one part 20%
sucrose in PBS to two parts OCT, and then 30 minutes in two parts 20% sucrose in PBS to one
part OCT. Finally, the retinas were embedded in two parts 20% sucrose in PBS to one part OCT
in Tissue-Tek Cryomolds (25 mm x 20 mm x 5 mm) using a dry ice/2-methyl butane bath after
the boiling stopped. Brains from 129S1/SvlmJ or DBA2/J mice were processed in the same
manner, except that final embedding was in 100% OCT. CFW mice were anesthetized by
administration of isofluorane gas (~10%) and transcardially perfused with 0.1 M PBS followed
by freshly prepared 2% paraformaldehyde/2% Histochoice MB Tissue Fixative in PBS. Following
fixation, spinal cords were removed and placed in the same fixative solution for a 6 hour
incubation at 4°C. After fixation, tissues were rinsed in PBS and cryoprotected by 30 minute
incubations in 10% sucrose–PBS solution, 20% sucrose–PBS solution, and finally 30% sucrose–
PBS solution. Following sucrose infusion, spinal cords were frozen in OCT matrix by embedding
within a cryomold in a dry ice/2-methyl butane bath, and stored at -80°C. Unfixed brains of
Sod1+/+ and Sod -/- mice were stored at -70°C and directly embedded in 100% OCT as described
above. Prior to cryosectioning, tissue blocks were placed in the chamber of a Microm HM 560
Cryostat (ThermoFisher Scientific) and allowed to equilibrate to the cutting temperature in the
chamber of a Leica CM 1850 cryostat. Coronal and sagittal cryosections (10–12 µm thick) were
obtained using a low profile microtome blade at -20°C to -22°C and thaw-mounted onto
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silanized Superfrost Plus slides. Sections were dried using a desiccator for 1 hour, and stored at
-70°C under desiccant until used for immunohistochemistry.

2.2.9 Immunohistochemistry of mouse tissue cryosections
For immunostaining, sections were rehydrated in PBS, permeabilized with 0.1% Triton X-100 in
PBS, and blocked for 1 hour in 5% cold fish skin gelatin in PBS. Incubation with primary antibody
solution (dilutions in 1% fish gelatin in PBS) was performed overnight at 4°C. Sections were then
rinsed three times in PBS, incubated for 1 hour at room temperature in the dark with a
fluorescent secondary antibody, washed 3 times in PBS, and mounted in Vectashield mounting
media (Vector Labs). Nuclei were counterstained with 1 µg/mL Hoechst 33342. Tissue
immunostaining controls included omission of the primary antibodies, incubation with preimmune serum, and incubation with antibody neutralized by immunizing peptide. None of
these immunohistochemistry controls revealed significant immunostaining beyond background.
The Zeiss LSM 710 confocal microscope and inverse Axio Observer (Carl Zeiss, Thornwood, NY)
were used for imaging tissue sections immunostained for Ac-K123 SOD1, rat SOD1, acetylatedα-tubulin, GFAP, doublecortin, NeuN, and calbindin D28K. Goat-anti-rabbit Alexa Fluor 488,
goat-anti-mouse Alexa Fluor 594, goat-anti-chicken Alexa Fluor 647, and donkey-anti-goat 594
conjugated secondary antibodies (1:250) were used for detection of primary antibodies. Images
were acquired and processed using Zen 2012 imaging software (Carl Zeiss, Thornwood, NY).
Composite images of acetyl-Lys123 SOD1 immunostained sagittal brain sections were created

21

using the stitching function in MetaMorph Image Analysis Software Version 7.1.3.0 (Molecular
Devices, Sunnyvale, CA).

2.2.10 Sod1-/- transgenic mice and protein extractions
Isolated brains from Sod1-/- or Sod1+/+ mice were frozen and stored at -70°C. Prior to tissue
lysate preparation, brains were equilibrated to -20°C for 30 minutes, minced into small pieces,
and 1 g tissue was resuspended in 10 mL ice-cold T-PER Tissue Protein Extraction Reagent with
200 µM NAM, 10 µM TSA, 10 µM Tubastatin A, Halt protease inhibitors, and Halt phosphatase
inhibitors. Following a 30 minute incubation on ice, tissues underwent five cycles of sonication
on ice (20 seconds at output 5 and 50% duty cycle) using a Branson Sonifer 450. Tissue lysates
were then passed through a syringe fitted with a 25½ gauge needle until no longer viscous.
Cellular debris was removed by centrifugation at 18,200 x g for 30 minutes at 4°C in an
Eppendorf 5417R microcentrifuge. Supernatants were collected and protein concentrations
were determined using a Pierce Bradford assay kit.

2.2.11 Cortical neuron isolation and transfection
Primary cortical neurons were isolated from fetal rat cortices dissected and prepared from one
litter of E18 Sprague Dawley rat embryos. Isolated neurons were seeded at a density of 1 x 105
cells/cm2 alone or upon an astrocyte feeder layer on poly-L-lysine pre-coated 12 mm diameter
#1 glass coverslips (Chemglass Life Sciences) for subsequent immunostaining analysis. For
expression of GFP-tagged recombinant Tau, isolated embryonic (E18) cortical neurons were
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transfected by electroporation. For transfections, 5x106 cells were mixed with 100 µL of Primary
Rat Neuron Nucleofector Solution (Amaxa, Lonza, Switzerland) and 2 µg pRK5-EGFP-Tau
plasmid DNA (Addgene, Cambridge, MA) and then electroporated using an Amaxa Nucleofector
I device (Lonza, Switzerland) following an optimized protocol for primary rat neurons provided
by the manufacturer.

2.2.12 Microscopy and image analysis
Imaging was carried out with a Zeiss LSM 710 Inverted Axio Observer confocal laser scanning
microscope with six laser excitation lines (405, 458, 488, 514, 543, and 633 nm), a 34 channel
QUASAR detector for spectral analysis, and several objectives including a EC Plan-Neofluar 10x
0.3 numeric aperture (NA) air objective, Plan-Apochromat 20x 0.8 NA air objective, EC PlanNeofluar 40x 1.3 NA oil objective, and a Plan-Apochromat 63x 1.4 NA oil objective. Image
acquisition and processing were performed using Zen 2012 software from Zeiss. To visualize
Hoechst 33342, the excitation/emission wavelength was 405/495 nm using the diode laser. For
Alexa Fluor 488, the excitation/emission wavelength was 488/540 nm using the multiline argon
laser. For Alexa Fluor 594, the excitation/emission wavelength was 543/660 nm using a diode
pumped solid state laser plus a QUASAR detector for all emission wavelengths. On average 25 zstacks of 0.5 µm step-size were acquired for 354 µm x 354 µm scaled image size. The z-stacks
were maximally projected and the gamma value adjusted to 0.70−0.85 using the ZEN 2012
software.
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Montage images were acquired using a Zeiss Axiovert Zeiss 100M fluorescence microscope with
a Plan‐Neofluar 10 × 0.3 NA or Plan‐Neofluar 20 × 0.5 NA air objective (Zeiss), a DG-4/ Xe-arc
illumination unit (Sutter Instruments), a BioPrecision 2 linear encoded XY-motorized stage
operated by a MAC 5000 modular control system (Ludl), and a Sensicam QE CCD camera (PCO
AG) controlled by MetaMorph 7.1 software (Molecular Devices). To visualize Ac-K123 SOD1Alexa 488, the excitation filter was S490/20x (Chroma) and the emission filter was S528/38m
(Chroma). To generate the montage, the “scan slide” function in Metamorph 7.1 was used. At
each z position in the scan slide area, a three dimensional image was acquired using the
“stream Z” module, generating an average of 100−400 image tiles (1x1 binning, 4 µm step size,
11 z-planes). The z-stacks were processed in MetaMorph 7.5 using the “remove haze” function
and maximally projected. Finally, the montage was stitched with a 10% image overlay using the
“make montage” function.
2.3 Results
2.3.1 Antibodies demonstrate specificity towards SOD1
To investigate the role of SOD1 K123 acetylation in the central nervous system, we generated
affinity purified polyclonal rabbit antibodies. Two independent rabbits (R25 and R26) were
immunized with an acetylated peptide (VVHE-AcK-ADDLGKGGC), representing SOD1119-131,
conjugated to the carrier protein thyroglobulin (Figure 4A). To test whether the antibodies
recognized SOD1, protein extracts were isolated from brains of Sod1+/+ or Sod1-/- mice,
separated by SDS-PAGE, and subjected to western blotting using Ac-K123 SOD1, total SOD1, or
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α-tubulin primary antibodies. Protein bands were detected by enhanced chemiluminescence
through the use of peroxidase-conjugated secondary antibodies. The Ac-K123 SOD1 antibodies
detected a single protein band corresponding to SOD1 in Sod1+/+ mice (Figure 4B). By contrast,
Sod1 gene deletion in Sod1-/- mice abolished Ac-K123 SOD1 antibody binding. Probing with
total SOD1 antibodies confirmed Sod1 gene deletion, and α-tubulin bands demonstrated equal
sample loading. The results indicate that our new Ac-K123 antibody is specific to SOD1.
Next, we tested specificity of the Ac-K123 SOD1 antibodies using immunohistochemistry.
Frozen brains of Sod1-/- or Sod1+/+ mice were embedded in OCT and post-fixed sagittal
cryosections were incubated with primary Ac-K123 SOD1 antibodies followed by detection with
fluorescently labeled secondary antibodies. Nuclei were visualized by counterstaining with
Hoechst 33342 fluorescent dye. Specificity of the immunolabeling was evaluated using confocal
scanning microscopy. Figure 4C shows representative confocal micrographs of the cerebellum
of Sod1-/- or Sod1+/+ mice. In Sod1+/+ mice (Figure 4C, upper panels) the Ac-K123 SOD1
antibodies stained cell bodies within the granular cell layer and molecular layer. By contrast, in
Sod1-/- mice no discernible immunostaining could be detected (Figure 4C, lower panels). These
results suggest that our custom antibodies are specific to SOD1 and can be used for
immunohistochemistry.
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Figure 4. Customized antibodies demonstrate specificity for SOD1.
A. Model of immunogenic peptide used for generation of Ac-K123 SOD1 antibodies. B. Western
blot of Sod1+/+ and Sod1-/- mouse brain lysates probed with Ac-K123 SOD1 (R25), SOD1, and
α-Tubulin antibodies. C. Confocal micrographs (scale bar, 200 µm) of Sod1+/+ and Sod1-/26

mouse cerebellum sagittal sections showing Ac-K123 SOD1 (R26) immunostaining, nuclear
Hoechst 33342 labeling, or merged image. The granular cell layer (GCL) and molecular layer
(ML) of the cerebellar cortex are identified. Below each image is a higher magnification confocal
micrograph (scale bar, 10 µm) of the GCL and ML. Insets show a 2.5x zoom of the boxed region.
2.3.2 Antibodies are specific to Lys123 acetylation
To examine antibody specificity to the K123 acetylated form of SOD1, we transfected HEK293
cells with expression vectors encoding SOD1 WT or the K123R mutant (where lysine was
replaced by an arginine making it resistant to acetylation). To differentiate from the
endogenous protein, SOD1 was tagged with EGFP. After 48 hours of expression, protein lysates
were generated, separated by SDS-PAGE, and processed by infrared fluorescence western
blotting. Transiently expressed SOD1 bands were easily distinguishable because endogenous
SOD1 has a molecular weight of approximately 16 kDa while EGFP-tagged SOD1 has a molecular
weight of 43 kDa. Infrared images indicate EGFP-SOD1 WT was recognized by both Ac-K123
SOD1 and SOD1 antibodies, as demonstrated by the overlapping bands in the merged image
(Figure 5A, left lane). By contrast, the acetyl-resistant EGFP-SOD1 K123R mutant was
recognized by SOD1 antibodies but not Ac-K123 SOD1 antibodies (Figure 5A, right lane). Thus,
the inability to recognize deacetylated mimetic SOD1 K123R, where lysine has been substituted
with arginine, suggests that the antibody is specific to the K123 acetylated form of SOD1.
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Figure 5. Antibodies are specific for K123-acetylated SOD1.
A. Western blot analysis of transfected HEK293 cells expressing SOD1 WT-EGFP or SOD1 K123REGFP. Ac-K123 SOD1 (R26) polyclonal and SOD1 mouse monoclonal antibodies were
fluorescently detected by infrared dye conjugated secondary antibodies. B. Western blot
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analysis of endogenous Ac-K123 SOD1 (R26) and total SOD1 levels in cell lysates from HEK293
cells that were treated with 10 mM nicotinamide and 1 µM trichostatin A (NAM/TSA) or vehicle
control for six hours. Bands were detected by chemiluminescence. C. Quantification of the
deacetylase treatment western blot results. Ac-K123 SOD1 band intensities from the blots in
(5B) were normalized to those of SOD1, and acetylation level of NAM/TSA treated cells were
plotted relative to those in control cells (n = 3, *significance at P<0.05 by Student's t-test). D.
Western blot analysis of whole cell extracts from deacetylase inhibitor treated HEK293 cells
using Ac-K123 SOD1 (R26) antibody that was pre-incubated with no peptide, immunogenic
acetylated K123 peptide at a 1:1 or 1:5 (antibody: peptide) molar ratio, unmodified K123
peptide at a 1:100 or 1:500 molar excess, or a mixture of acetylated (1:1) and unacetylated
(1:100) K123 peptide. E. Quantification of the antibody preabsorption western blot results. AcK123 SOD1 band intensities from the blots in (5D) were normalized to those of SOD1 and
plotted as percentage of K123 acetylation relative to the antibody alone (n = 3, ** and ****
significance at P<0.01 and P<0.0001 by ANOVA, respectively). F. Confocal micrograph (scale bar,
100 µm) of cerebellum immunostained with Ac-K123 SOD1 (R26) antibody pre-incubated with
unacetylated peptide at 1:5 molar ratio prior to immunohistochemistry. S. Blaes performed
tissue embedding and cryosectioning. G. Confocal micrograph (scale bar, 100 µm) of cerebellum
immunostained with Ac-K123 SOD1 (R26) antibody preabsorbed with acetylated peptide at 1:5
molar ratio prior to immunohistochemistry. S. Blaes performed tissue embedding and
cryosectioning. GCL, granular cell layer; ML, molecular layer.

Next, because SOD1 is also succinylated at K123 (Lin et al., 2013) we needed to confirm that our
antibody recognized K123 acetylation and not another PTM. To do this, we assessed the
detection of endogenous SOD1 K123 acetylation in HEK293 cells treated with either broadspectrum deacetylase inhibitors (NAM/TSA) or a vehicle control. After a six-hour treatment,
cells were lysed and resolved by SDS-PAGE for western blot analysis. Vehicle-control treated
cells exhibited a weak signal for Ac-K123 SOD1 (Figure 5B, left lane). By contrast, deacetylase
inhibition dramatically increased Ac-K123 SOD1 signal (Figure 5B, right lane). Reprobing the blot
with antibodies for total SOD1 indicated that the amount of total SOD1 was similar in both
samples (Figure 5B). To quantify the results, we performed densitometric analysis of three
independent western blots and observed a four-fold increase in Ac-K123 SOD1 in deacetylase
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inhibited cells (Figure 5C). Taken together, these data support that the increased signal
detected in deacetylase inhibitor treated cells is due to increased Ac-K123 SOD1 levels, and that
the antibody is indeed recognizing acetylation of K123.
Similar to other proteins modified by lysine acetylation, only a small fraction of total SOD1 is
predicted to be acetylated (Choudhary et al., 2014). Therefore, despite the use of an affinity
matrix during purification (Section 2.2.2), it was important to verify the absence of antibody
cross-reactivity with unacetylated SOD1. To assess any cross-reactivity, we performed western
blots of deacetylase inhibitor treated lysate using antibody that was pre-incubated with no
peptide, acetylated K123 peptide, unacetylated K123 peptide, or a mixture of acetylated and
unacetylated peptide. Pre-incubation of the antibody alone resulted in a strong signal for AcK123 SOD1 (Figure 5D, lane 1). As expected, preabsorption with acetylated peptide at 1:1 and
1:5 (antibody:peptide) molar ratios totally eliminated antibody binding to Ac-K123 SOD1 (Figure
5D, lanes 2 and 3). By contrast, preabsorption with unacetylated peptide even at 100 and 500
molar excess failed to eliminate binding (Figure 5D, lanes 4 and 5). Finally, pre-incubation with a
mixture of both acetylated peptide (1:1) and unacetylated peptide (1:100) also resulted in loss
of signal by western blot (Figure 5D, lane 6). Densitometric analysis of three independent
western blots is shown in Figure 5E, with the quantification confirming that preabsorption with
acetylated peptide at low molar ratios totally eliminated antibody binding to Ac-K123 SOD1.
Conversely, unacetylated peptide did not abolish antibody recognition of Ac-K123 SOD1. In fact,
even a 500 fold molar excess of unacetylated peptide failed to cause any significant reduction in
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detection of Ac-K123 SOD1. Combined, these western blot results confirm antibody specificity
to Ac-K123 SOD1 and demonstrate an absence of cross-reactivity to unmodified SOD1.
Finally, to confirm antibody specificity by immunohistochemistry, we probed cerebellar tissue
sections with Ac-K123 SOD1 antibodies pre-incubated with the unacetylated or acetylated
peptides. In tissue stained with Ac-K123 antibodies pre-incubated with unacetylated peptide,
staining was evident in cell bodies of the granular cell layer (GCL) and molecular layer (ML) and
processes extending through the molecular layer (Figure 5F). By contrast, in tissue stained with
Ac-K123 antibodies preabsorbed with acetylated peptide the staining pattern was abolished
(Figure 5G). In addition to preabsorption of the Ac-K123 SOD1 antibody, we performed other
negative controls including Ac-K123 SOD1 primary antibody omission and incubation with preimmune serum. The lack of discernible immunostaining from the Sod1-/- tissue and within the
negative controls validates antibody specificity for Ac-K123 SOD1.
In summary, these findings strongly indicate that our antibody is specific for Ac-K123 SOD1. The
antibody showed increased detection of Ac-K123 SOD1 in lysate derived from cells treated with
deacetylase inhibitors, while failing to recognize acetylation-resistant SOD1 expressed in
transfected cells. Preabsorption of antibodies to acetylated peptide prevented binding to AcK123 SOD1 in western blots, fixed cells, and tissue sections, further demonstrating specificity to
acetylated K123.
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2.3.3 Ac-K123 SOD1 localizes to hippocampal pyramidal neurons and granule cells of the
dentate gyrus
SOD1 carries out important neuromodulatory functions within the hippocampus. Secreted
SOD1 modulates synaptic transmission and inhibits long-term potentiation, the long-lasting
form of synaptic enhancement linked to learning and memory, within the dentate gyrus and
cornus ammonis region 1 (CA1) of the hippocampus (Knapp and Klann, 2002; Viggiano et al.,
2012). SOD1 deficiency exacerbates memory loss and amyloid deposition in a mouse model of
AD, and SOD1 levels are significantly decreased in human AD patients (Murakami et al., 2011).
Based on these important functions and previous findings, we sought to analyze Ac-K123
distribution within the hippocampus and dentate gyrus by immunostaining sagittal brain
sections with Ac-K123 SOD1 antibodies.
A micrograph montage of the hippocampal region showed Ac-K123 SOD1 immunostaining was
most prominent in the fimbria, the principle hippocampal pathway that connects to subcortical
regions, and subiculum, the major hippocampal output structure adjacent to CA1 (Figure 6A).
Within the hippocampus labeling of CA1 was observed, while region CA3 stained less strongly
(Figure 6A). Staining was also observed in the dentate gyrus, the major target of cortical input
to the hippocampus. Cells lining the lateral ventricle wall and from the surrounding cortex were
also labeled, and diffuse staining was observed in the corpus callosum (Figure 6A).
Closer examination of the hippocampus indicated Ac-K123 SOD1 localization to CA1 stratum
pyramidale cell bodies and processes within the CA1 stratum radiatum (Figure 6B). The CA1
stratum pyramidale mostly consists of pyramidal neurons, which receive input from Schaffer
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collaterals and send axons to the subiculum and entorhinal cortex. Also present within this
layer, at a much lower density, are the soma and processes of local circuit inhibitory
interneurons that include axo-axonic, basket, bistratified, and radial trilaminar cells. The CA1
stratum lacunosum-moleculare, an important layer where performant pathway fibers from the
entorhinal cortex synapse onto apical dendrites of CA1 pyramidal cells, also exhibited strong
labeling (Figure 6B). Staining was also observed in the dentate gyrus within granule cells, the
principal excitatory neurons of the dentate gyrus, and in cell bodies of the molecular layer and
polymorphic layer (Figure 6B).
We used a higher magnification view of the CA1 stratum pyramidale to better assess labeling of
pyramidal neuron cell bodies and processes of the stratum radiatum. Co-labeling with
antibodies against NeuN, neuron-specific marker of the nucleus and cytoplasm, confirmed AcK123 SOD1 localization to neuronal cell bodies within the stratum pyramidale (Figure 6C). These
labeled cell bodies are tightly packed and layered in a characteristic pattern for pyramidal
neurons of the hippocampus. A characteristic of CA1 pyramidal cells is the presence of a single
apical dendrite that branches into secondary oblique dendrites farther away from the soma.
Immunostaining results demonstrated Ac-K123 SOD1 distribution to the apical dendrites
extending from pyramidal neurons into the CA1 stratum radiatum (Figure 6C). Interestingly,
labeling was not observed in any dendritic branches emanating from the apical dendrites of
pyramidal neurons. Based on the closely arranged soma in the stratum pryamidale and the
homogenous morphology of processes that extend into the stratum radiatum, the observed Ac-
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K123 labeling within these layers can mostly, if not exclusively, be attributed to pyramidal
neurons.
Next, we assessed immunostaining of the dentate gyrus granule layer cell bodies at higher
magnification. Interestingly, Ac-K123 SOD1 labeling did not appear to be uniform (Figure 6D).
Because of this uneven Ac-K123 SOD1 staining pattern of granule cells and the important role
of this region in adult neurogenesis (the dentate gyrus is one of two neurogenic zones in the
adult brain) (Ming and Song, 2011), we sought to explore any possible relationship between AcK123 SOD1 and neuronal development. Adult hippocampal neurogenesis originates from radial
glia-like precursor cells in the subgranular zone of the dentate gyrus and culminates with
generation of mature granule cell neurons. To examine Ac-K123 SOD1 in cells undergoing this
process, brain tissue was co-labeled with antibodies against doublecortin, a microtubuleassociated protein involved in neuronal migration and a marker for adult neurogenesis.
Doublecortin expression is transient and tapers off in mature neurons (Brown et al., 2003). AcK123 SOD1 immunostaining was strongest in the nuclei of doublecortin-positive immature
granule cells of the dentate gyrus (Figure 6D), demonstrating that acetylation of K123 in SOD1
might decrease once granule cells reach maturity.
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Figure 6. Distribution of Ac-K123 SOD1 within dentate gyrus granule cells and CA1 field
hippocampal neurons.
A. Sagittal view micrograph montage (scale bar, 200 µm) of the hippocampal region
immunostained with Ac-K123 SOD1 (R26) antibodies. Areas of interest include the subiculum
(Sub), fimbria (Fim), corpus callosum (CC), cortex (CTX), lateral ventricle (VL), dentate gyrus
(DG), hippocampus CA1 field (CA1), and hippocampus CA3 field (CA3). Ac-K123 SOD1 labeling
within cells lining the ventricle wall is also shown (arrows). S. Blaes performed tissue
embedding and cryosectioning and A. Kennedy performed wide-field fluorescence microscopy
and image montage stitching. B. Confocal micrograph (scale bar, 100 µm) of the dentate gyrus
and CA1 field of the hippocampus proper labeled with Ac-K123 SOD1 (R26) antibodies and
Hoechst 33342. Dentate gyrus regions include the granule layer (GL), polymorph layer (PM),
and molecular layer (ML). The CA1 layers shown are the stratum pyramidale (SP), stratum
radiatum (SR), and stratum lacunosum-moleculare (SLM). S. Blaes performed tissue embedding
and cryosectioning. C. Confocal micrograph (scale bar, 20 µm) of hippocampus CA1 field
pyramidal neurons immunostained with antibodies against Ac-K123 (R26) SOD1 and the adult
neuron specific marker NeuN. D. Confocal micrograph (scale bar, 20 µm) showing the GL of the
dentate gyrus immunostained with antibodies against Ac-K123 SOD1 (R26) and doublecortin.
Immature adult granule neurons are noted (arrows). Insets show a 2.5x zoom of the boxed
regions of merged image.

In summary, immunostaining of the hippocampus region resulted in strong Ac-K123 SOD1
labeling of neuronal tracts, including the subiculum and fimbria. The principal neurons within
the hippocampus and dentate gyrus, the pyramidal and granule cells, also stained for Ac-K123
SOD1. CA1 pyramidal cells of the hippocampus exhibited Ac-K123 SOD1 localization to soma
and along apical dendrites. Ac-K123 SOD1 was also found in the soma of dentate gyrus granule
cell layer and appeared to be highest in immature granule cells. Interestingly, SOD1 K123
acetylation may be at its highest in cells undergoing neuronal maturation. If this is indeed the
case, Ac-K123 SOD1 represents a novel biomarker for assessing adult neurogenesis within the
dentate gyrus.

36

2.3.4 Ac-K123 SOD1 is found in granular cell bodies and molecular layer axons of cerebellum
The cerebellum is a dorsal structure important for control and coordination of movement. In
order to investigate the distribution of Ac-K123 SOD1 within the cerebellum, we performed
immunostaining of sagittal brain sections. A low magnification micrograph montage of the
cerebellum showed strong Ac-K123 SOD1 labeling of the granular cell layer within the highly
convoluted cerebellar cortex (Figure 7A). The molecular layer of the cortex exhibited less
intense labeling, while the central core of white matter known as the arbor vitae was mostly
void of Ac-K123 SOD1 staining.
A higher magnification view allowed better evaluation of Ac-K123 SOD1 distribution within the
three layers of the cerebellar cortex: the granular cell layer, Purkinje cell layer, and molecular
layer. The most intense immunostaining was observed in the somata of small, densely packed
glutamatergic neurons of the granular cell layer, the only excitatory neurons of the cerebellar
cortex (Figure 7B). Staining was also observed in cell bodies and processes extending through
the molecular layer (Figure 7B, inset). Weak staining was observed in the Purkinje cell layer,
where the somata of Purkinje cells reside.
To further examine Purkinje cell staining, tissue was co-stained with antibodies against
calbindin D28K, a calcium-binding protein and Purkinje cell marker. The GABAergic Purkinje
cells are the sole source of output from the cerebellar cortex, making inhibitory connections
onto the cerebellar nuclei. Previous immunohistological examination demonstrated that SOD1
was present throughout all cortical layers of the cerebellum, including cell bodies, dendrites,
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and axons of Purkinje cells (Yokoyama et al., 2014). Interestingly, we observed weak Ac-K123
SOD1 labeling within the soma of Purkinje cells compared to cells of other cortical layers (Figure
7C).
We next focused on the distribution of Ac-K123 SOD1 within the molecular layer. This
outermost layer of the cerebellar cortex comprises granule cell axons, Purkinje cell dendritic
arbors, basket and stellate cell interneurons, and glial cells. In order to identify neurons,
sections were co-stained with antibodies against the neuron-specific class III β-tubulin (Tuj1).
We found that Ac-K123 SOD1 localized to the soma of molecular layer interneurons (Figure 7D).
The cerebellar stellate cells, which are located in outer molecular layer regions and synapse
onto the dendritic arbors of Purkinje cells, and basket cells, located immediately above the
Purkinje cell layer and forming elaborate branches around Purkinje cell bodies, were identified
by both location and positive labeling for Tuj1 (Figure 7D). Labeling was also observed within
neuronal processes extending into the molecular layer, demonstrating Ac-K123 SOD1
distribution to Purkinje cell dendritic arbors and possibly the axons of granule cells (Figure 7D).
Cerebellar immunostaining demonstrated strong Ac-K123 SOD1 labeling in the soma of granule
cells and molecular layer interneurons. Purkinje cell bodies exhibited less pronounced Ac-K123
SOD1 staining, as did neuronal processes extending into the molecular layer.

38

39

Figure 7. Ac-K123 SOD1 localization within granule, basket, and stellate cell somata and
molecular layer neurites of the cerebellum.
A. Sagittal view micrograph montage (scale bar, 500 µm) of cerebellum showing Ac-K123 SOD1
(R26) immunostaining within the cerebellar cortex and underlying arbor vitae (Arb). The
cerebellar cortex granule cell layer (GCL) and molecular layer (ML) are noted. S. Blaes
performed tissue embedding and cryosectioning and A. Kennedy performed wide-field
fluorescence microscopy and image montage stitching. B. Confocal micrograph (scale bar, 50
µm) demonstrating Ac-K123 SOD1 (R26) immunostaining in the cerebellum. Shown is the
cerebellar cortex layers, consisting of the GCL, Purkinje cell layer (PCL), and ML. Inset shows a
2x zoom of the boxed region demonstrating Ac-K123 SOD1 labeled processes within the ML
(arrow). S. Blaes performed tissue embedding and cryosectioning. C. Higher magnification
confocal micrograph (scale bar, 20 µm) of GCL, PCL, and ML immunostained for Ac-K123 SOD1
(R26) and Calbindin D28K with nuclear counterstaining by Hoechst 33342. S. Blaes performed
tissue embedding and cryosectioning. D. Confocal micrograph (scale bar, 20 µm) of GCL, PCL,
and ML immunostained for Ac-K123 SOD1 (R26) and Tuj1. Examples of stellate cells (SC) and
basket cells (BC) are marked by arrows.
2.3.5 Ac-K123 SOD1 in ependymal cells of ventricle and choroid plexus
Recent findings have identified SOD1 in human cerebral spinal fluid (CSF) samples (Winer L et
al., 2013). The CSF bathes the central nervous system exterior and is vital for normal brain
function, acting as a mechanical cushion and creating an optimal environment for neuronal cells
(Speake et al., 2001). Because the mechanism of entry and role of SOD1 in the CSF has yet to be
determined, we sought to explore whether Ac-K123 SOD1 is present in specific regions of the
brain in contact with CSF.
Analysis of immunostained sagittal sections demonstrated Ac-K123 SOD1 labeling of choroid
plexus cells within the 4th ventricle of the brain (Figure 8A). CSF is produced by the four choroid
plexuses, branched epithelial structures found within each ventricle of the brain (Speake et al.,
2001). Ac-K123 SOD1 labeling was also observed in ependymal cells lining the ventricle wall
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(Figure 8A). These multi-ciliated cells are specialized glia involved in the directional movement
of CSF.
A higher magnification view confirmed strong SOD1 K123 acetylation within cuboidal epithelial
cells of the choroid plexus and ependymal cells, the ciliated cells lining the ventricle wall
involved in the directional movement of CSF (Figure 8B). Ac-K123 SOD1 is primarily distributed
to the nucleus and cytoplasm of choroid plexus epithelial cells and ependymal cells.
These findings, demonstrating Ac-K123 SOD1 distribution within choroid plexus and ependymal
cells, merit further investigation into the role of SOD1 K123 acetylation during the production
and circulation of CSF.
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Figure 8. Ac-K123 SOD1 localization in choroid plexus and ependymal cells.
A. Sagittal view confocal micrograph (scale bar, 100 µm) of 4th ventricle immunostained for AcK123 SOD1 (R26). Identified are the choroid plexus (CP) and ventricle wall ependymal cells
(Ependyma). S. Blaes performed tissue embedding and cryosectioning. B. Higher magnification
confocal micrograph (scale bar, 50 µm) of CP and Ependyma immunostained for Ac-K123 SOD1
(R26) and Ac-K40 α-Tubulin. Nuclei were counterstained with Hoechst 33342. S. Blaes
performed tissue embedding and cryosectioning.
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2.3.6 Ac-K123 SOD1 localizes to interneuron cell bodies and the major afferent and efferent
neuronal processes of the olfactory bulb
SOD1 is ubiquitously expressed throughout the nervous system of developing and adult mice,
including within areas important for olfaction. The oval-shaped olfactory bulb, located in the
rostral portion of the forebrain, is the main center in the mouse olfactory system. Olfactory
bulb alterations, including vacuolar lesions, have been observed in mutant SOD1 transgenic
mice (Dal Canto and Gurney, 1995; Wong et al., 1995). Loss of smell has been observed in ALS
patients and excessive lipofuscin deposition has been noted in the mitral and tufted cells of
their olfactory bulbs (Elian, 1991; Hawkes et al., 1998). To better understand the pattern of
SOD1 Lys123 acetylation within the adult mouse olfactory system, we examined Ac-K123 SOD1
immunostaining within the olfactory bulb.
Examination of main olfactory bulb coronal sections indicated strong Ac-K123 SOD1 antibody
staining of the olfactory nerve layer, the surface of the olfactory bulb formed by afferent
projections of the olfactory sensory neurons (Figure 9A). Previous immunohistochemical
analysis identified high SOD1 immunoreactivity in olfactory sensory neurons (Yon et al., 2008),
which are responsible for detection of odorants through their odorant receptors. Axons from
olfactory sensory neurons project toward the main olfactory bulb, where they synapse with
second-order neurons, the mitral and tufted cells, in specialized compartments called
glomeruli.
When viewed at lower magnification, the glomerular layer was for the most part void of
staining with the exception of weak labeling in the cell bodies surrounding glomeruli (Figure
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9A). Beyond the glomerular layer, Ac-K123 SOD1 staining was observed in processes running
through the outer plexiform layer, internal plexiform layer, and granule cell layer (Figure 9A).
Cell bodies of the granule cell layer also exhibited Ac-K123 SOD1 labeling (Figure 9A).
To better assess Ac-K123 SOD1 staining of the glomerular layer, we examined this region at
higher magnification. Staining results clearly demonstrated Ac-K123 SOD1 distribution within
the soma of periglomerular cells, the small interneurons adjacent to the glomeruli, and
processes within the olfactory glomeruli core (Figure 9B). These processes are neuronal, as they
did not co-label with antibodies against GFAP, an intermediate filament protein specific to
astrocytes (Figure 9C). These Ac-K123 SOD1 positive neurites within the glomeruli core could be
either olfactory sensory neuron axons or primary dendrites of mitral and tufted cells.
A higher magnification view also showed Ac-K123 SOD1 staining of processes in the outer
plexiform layer (Figure 9D). This layer contains the soma of tufted cells, basal dendrites of
tufted and mitral cells, and apical dendrites of granule cells. Within the mitral cell layer,
crossing processes showed strong Ac-K123 SOD1 labeling while large mitral cell bodies were
weakly stained (Figure 9D). In the internal plexiform layer, through which axons of mitral and
tufted cells course, staining was observed within processes (Figure 9D). Similar to the
periglomerular interneurons, cells within the granule cell layer exhibited Ac-K123 SOD1
distribution within their soma (Figure 9D). These GABAergic granule cells, the principal
interneurons of the olfactory bulb, modulate mitral and tufted cell activity by inhibitory
feedback. In addition to the granule cell soma, Ac-K123 SOD1 was observed within processes of
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the granule cell layer (Figure 9D). Mitral and tufted cells project axons through this layer,
eventually emerging from the caudal portion of the olfactory bulb to form the lateral olfactory
tract. These efferent fibers of the lateral olfactory tract connect the olfactory bulb to several
central brain regions via collateral branching (Schwob and Price, 1984).
A sagittal view of the posterior olfactory bulb identified Ac-K123 SOD1 within axonal tracts
extending through the lateral olfactory tract in the area of the olfactory peduncle, the region
that connects the olfactory bulb with the basal forebrain. From this view, Ac-K123 SOD1 was
also observed in cell bodies of the olfactory bulb granule cell layer (Figure 9E).
In summary, olfactory bulb immunostaining demonstrated Ac-K123 SOD1 localization to cell
bodies of interneurons and along processes of the major afferent neurons (olfactory sensory
neurons) and efferent neurons (mitral and tufted cells).
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Figure 9. Ac-K123 SOD1 within the olfactory bulb and lateral olfactory tract.
A. Confocal micrograph (scale bar, 100 µm) showing Ac-K123 SOD1 (R26) immunostaining,
Hoechst nuclear counterstaining, and 3x merged image of the posterior main olfactory bulb in
the coronal plane. Identified regions include olfactory nerve layer (ONL), glomerular layer (GL),
outer plexiform layer (OPL), mitral cell layer (MCL), inner plexiform layer (IPL), and granule cell
layer (GCL). B. Confocal micrograph (scale bar, 20 µm) of GL immunostained for Ac-K123 SOD1
(R26). An example of a neurite extending into the glomerulus is also labeled (arrow). C.
Confocal micrograph (scale bar, 20 µm) of an olfactory glomerulus core within the GL labeled
for Ac-K123 SOD1 (R26) and GFAP. An example of a neurite labeled with Ac-K123 SOD1 and not
GFAP is shown (arrow). D. Confocal micrograph of the OPL, ML, IPL, and GCL immunostained for
Ac-K123 SOD1 (R26) (scale bar, 20 µm). Granule cell processes and tufted or mitral cell primary
axons are labeled (arrows). E. Sagittal view confocal micrograph (scale bar, 100 µm) of posterior
olfactory bulb showing axonal tracts extending through the lateral olfactory tract (LOT) in the
area of the olfactory peduncle. Immunostaining of olfactory bulb was performed with
antibodies against Ac-K123 SOD1 (R26) and nuclei were counterstained with Hoechst 33342. S.
Blaes performed tissue embedding and cryosectioning (Figure 6E).
2.3.7 Ac-K123 SOD1 is found with specific layers of the retina
SOD1 plays an important protective role in the retina, an area particularly susceptible to
oxidative stress. Decreased SOD1 function has been shown to be detrimental to retinal health.
SOD1-deficient mice develop age-related retinal degenerative disorders, including macular
degeneration (Hashizume et al., 2008; Imamura et al., 2006), and the lens from SOD1-deficient
mice has been shown to have increased superoxide levels with accelerated cataract
development compared to control mice (Behndig et al., 2001). Age-dependent dry eye also
develops in SOD1-deficient mice due to lacrimal gland dysfunction (Kojima et al., 2012).
Therefore, we performed immunohistochemistry on vertical sections of mouse retina with AcK123 SOD1 antibodies and Hoechst nuclear counterstaining.
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Ac-K123 SOD1 staining was detected in cell bodies within the retinal ganglion cell layer, inner
nuclear layer, and outer nuclear layer (Figure 10A). Strong labeling was observed within the
retinal ganglion cell layer, the site where light first enters before penetrating all other retinal
layers. This retinal layer contains cell bodies of retinal ganglion cells, the output neurons of the
retina whose axons merge to form optic nerve fibers that transmit visual information to the
brain.
Labeling was also observed within soma of the inner nuclear layer (Figure 10A), which contains
the cell bodies of bipolar, horizontal, amacrine, and Müller cells. Bipolar cells transmit signals
from the photoreceptors to the ganglion cells, amacrine cells form an alternative route
between bipolar and ganglion cells, and horizontal cells modulate visual signals through lateral
inhibition of neighboring photoreceptor cells. Müller cells, the principal glial cell of the retina,
are radial glia that span the entire retina and provide architectural support.
The staining of cell bodies within the outer nuclear layer was strong but less uniform than that
of the retinal ganglion cell layer and inner nuclear layer (Figure 10A). The outer nuclear layer
contains the cell bodies of rods and cones, the photoreceptor cells responsible for photon
detection and transduction into electrochemical signals. Based on the anatomical distribution
of rods and cones, namely that the density of rods is much greater than cones throughout most
of the retina, we surmise that the relatively sparse number of Ac-K123 SOD1 positive outer
nuclear layer cell bodies are those of cone cells. Because it has been shown that SOD1 is an
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important component of the antioxidant defense system of cones (Usui et al., 2011), our finding
of Ac-K123 SOD1 within the cones of the outer nuclear layer is of high interest.
Ac-K123 SOD1 staining was evident within the neurites of the inner plexiform layer, the area of
synaptic contact between the bipolar cell axons and the dendrites of the ganglion and amacrine
cells (Figure 10A). Not surprisingly, weaker Ac-K123 SOD1 labeling was observed in the outer
plexiform layer, the much thinner layer of processes where projections of rods and cones
terminate and synapse with dendrites of bipolar and horizontal cells (Figure 10A). Ac-K123
SOD1 exhibited strong localization to retinal ganglion cell neurites (Figure 10A). The strongest
Ac-K123 SOD1 staining of retinal processes was observed in the retinal ganglion cell layer
(Figure 10A). As the integrity of these processes varied throughout the retinal sections, we
sought out sections with intact processes to better assess Ac-K123 SOD1 labeling within the
retinal ganglion cell layer. Results from selected sections demonstrated Ac-K123 SOD1
distribution to both retinal ganglion cell bodies and neurites (Figure 10B). Closer examination of
this layer indicated Ac-K123 SOD1 labeling of retinal ganglion cell axons, the long processes
emerging from the retinal ganglion cell bodies (Figure 10B, inset).
In summary, our immunostaining results demonstrated that Ac-K123 SOD1 was localized to cell
bodies within the inner nuclear and ganglion cell layers, as well as cone cells of the outer
nuclear layer. Ac-K123 SOD1 was also distributed along retinal ganglion cell axons and
processes coursing through the inner plexiform layer. It was previously shown that SOD1,
because of its superoxide scavenging activity, is indispensable to retinal ganglion cells, and
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SOD1 deficiency causes retinal ganglion cell vulnerability and death (Yuki et al., 2011). SOD1 has
also been shown to play an important neuroprotective role against N-methyl-d-aspartateinduced cytotoxicity in retinal ganglion and inner nuclear layer cells (Yuki et al., 2013). Because
our immunostaining results indicated high levels of Ac-K123 SOD1 within these regions, it will
be worthwhile to investigate if there is a correlation between SOD1 K123 acetylation and
retinal neuron survival.
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Figure 10. Ac-K123 SOD1 localization to retinal ganglion cells, outer and inner nuclear layer cell
bodies, and inner plexiform layer neurites.
A. Confocal micrograph (scale bar, 50 µm) of a vertical section through the mouse retina
showing Ac-K123 SOD1 (R26) immunostaining with nuclear counterstaining by Hoechst 33342.
Identified retinal layers include the inner segments of photoreceptor (IS), outer nuclear layer
(ONL), outer plexiform layer (OPL), inner nuclear layer (INL), inner plexiform layer (IPL), and
retinal ganglion cell layer (RGCL). B. Fluorescence micrograph (scale bar, 50 µm) of a vertical
section through the mouse retina demonstrating Ac-K123 SOD1 (R26) distribution within RGCL
and IPL. Inset shows a 2x zoom of the boxed region containing a labeled RGC axon. A. Kennedy
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performed immunostaining (Figure 10A), confocal microscopy (Figure 10A), and wide-field
microscopy (Figure 10B). S. Blaes performed tissue embedding and cryosectioning (Figure 10AB) and immunostaining (Figure 10B).
2.3.8 Ac-K123 SOD1 localizes to neurites and the nucleus in cortical neurons
To determine the localization of Lys123 acetylated SOD1 within neurons, we immunostained
pure rat cortical neuron cultures with our antibody against Ac-K123 SOD1. Our findings show
acetylated Lys123 SOD1 is predominantly found within the nucleus and neurites of primary
cortical neurons (Figure 11A). The staining pattern of the neurites was noteworthy, as a strong
but discontinuous staining pattern was observed within the neuronal processes (Figure 11B).

Figure 11. Lys123 acetylated SOD1 is localized within somata and neurites of cortical neurons.
A. Fluorescent micrograph (scale bar, 10 µm) of cultured rat primary cortical neurons
immunostained for Ac-K123 SOD1. B. Fluorescent micrograph (scale bar, 30 µm) of cultured rat
primary cortical neurons immunostained for Ac-K123 SOD1. Inset shows a 3x zoom of the
boxed region demonstrating a discontinuous staining pattern of neurites. A. Kennedy
performed immunostaining and wide-field microscopy (Figure 11A-B).
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Additional immunostaining was done to evaluate whether Ac-K123 SOD1 detected in neurites
was restricted to dendrites or axons. Immunostaining of neuron and astrocyte mixed cultures
showed that Ac-K123 SOD1 localized to both the nucleus and dendrites of cortical neurons.
Dendritic staining was confirmed by co-localization with microtubule-associated protein 2
(MAP2), while nuclear localization was confirmed by Hoechst counterstaining (Figure 12A). The
Ac-K123 SOD1 labeled primary cilia observed in these cultures are from surrounding astrocytes
(Figure 12A). These surrounding cells were confirmed to be astrocytes by positive co-labeling
for GFAP (Figure 12B), and the origination of Ac-K123 SOD1 labeled primary cilia from
astrocytes was clearly demonstrated through analysis of z-series confocal micrographs.
However, Ac-K123 SOD1 localization to neuronal primary cilia should not be excluded. Most
neurons contain primary cilia, and co-labeling with a neuronal ciliary marker was not
performed. Unlike in astrocytes and many other cell types, Ac-K40 α-tubulin is not a marker for
neuronal primary cilia. It should be noted that primary cilia were shown to be present in these
cultured primary cortical neurons by immunostaining for type III adenylyl cyclase (ACIII), a
marker for neuronal primary cilia (Figure 12C). Unfortunately ACIII and Ac-K123 SOD1 colabeling was not performed due to both antibodies originating from the same host species.
Analysis of immunostained astrocyte and neuron mixed cultures also revealed long processes
staining for Ac-K123 SOD1, but not MAP2. To evaluate whether Ac-K123 SOD1 localizes to
axons, neurons were transfected with an expression plasmid for GFP-tagged Tau and
immunostained for Ac-K123 SOD1 three days post transfection. Immunostaining of transfected
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primary cortical neurons expressing Tau-GFP confirmed the axonal localization of Ac-K123 SOD1
(Figure 12D).

Figure 12. Lys123 acetylated SOD1 is localized within dendrites and axons of cortical neurons.
A. Confocal micrograph (scale bar, 10 µm) of primary cortical neurons co-cultured with primary
astrocytes and immunostained for Ac-K123 SOD1 and the dendritic marker MAP2. Ac-K123
SOD1 labeling of primary cilia is also shown (arrows). B. Confocal micrograph (scale bar, 10 µm)
of primary cortical neurons co-cultured with primary astrocytes and immunostained for AcK123 SOD1 and the astrocytic marker GFAP. Inset shows a 3x zoom of the boxed region
demonstrating a primary cilium labeled for Ac-K123 SOD1 originating from an astrocyte. C.
Confocal micrograph (scale bar, 10 µm) of primary cortical neurons immunostained for Ac-K40
α-tubulin and ACIII, a marker for neuronal primary cilia. ACIII labeling of a primary cilium is also
shown (arrow). D. Confocal micrograph (scale bar, 10 µm) of transfected primary cortical
neurons expressing Tau-GFP and immunostained for Ac-K123 SOD1. H. Hauser performed
transfection (Figure 12D). A. Kennedy performed confocal microscopy (Figure 12D).
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2.4 Discussion
SOD1 is acetylated at K123 within the electrostatic loop, a functional domain critical to
enzymatic function and structural stability. Prior to our current study, the impact of this PTM
had yet to be investigated. To gain a better understanding of SOD1 K123 acetylation, we
generated rabbit polyclonal antibodies against Ac-K123 SOD1. Herein, we demonstrated
specificity of this new antibody and described the distribution of Ac-K123 SOD1 within the
normal nervous system.
In the cerebellar cortex, strongest Ac-K123 SOD1 immunoreactivity was observed in the
glutamatergic granule cells. The soma of glutamatergic dentate granule cells and CA1 pyramidal
cells were strongly stained for Ac-K123 SOD1 within the hippocampal formation. The strongest
Ac-K123 SOD1 labeling of the olfactory bulb was along olfactory sensory neuron fibers and
axons of glutamatergic tufted and mitral cells. In the retina, the glutamatergic ganglion cells
exhibited the highest levels of Ac-K123 SOD1. Inner nuclear layer cell bodies and glutamatergic
outer nuclear layer cone cells also exhibited considerable Ac-K123 SOD1 immunoreactivity. This
would suggest that SOD1 K123 acetylation is optimized within functionally distinct neuronal
subtypes.
Another key finding was the localization of Ac-K123 SOD1 within processes of major afferent
and efferent neurons. In the hippocampal formation, tracts of the subiculum and fimbria were
strongly labeled, as were apical dendrites of the efferent CA1 pyramidal cells. Strong Ac-K123
SOD1 labeling was also noted within mitral and tufted cell axonal projections of the olfactory
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bulb, along fibers coursing through the lateral olfactory tract, and in the efferent axons of
retinal ganglion cells. The propensity of Ac-K123 SOD1 to localize within long axonal projections
of afferent and efferent neurons, as opposed to the shorter processes of interneurons, merits
further study. It is possible that Ac-K123 SOD1 interacts with proteins specific to these axons,
such as phosphorylated neurofilament heavy chain proteins, which are predominantly found in
larger axons.
A noteworthy finding from the immunostaining of primary cortical neurons is the unique
localization pattern observed within neuronal processes. This pattern is of interest because
discontinuous staining is often indicative of microtubule-based transport. Mutant SOD1 has an
increased propensity to interact with microtubule motor proteins and cargo linkers, resulting in
impaired axonal transport (De Vos et al., 2007; Warita et al., 1999; Williamson and Cleveland,
1999). Because one of the effects of protein acetylation is altered protein-protein interaction, it
will be interesting to investigate how SOD1 acetylation impacts axonal transport in neurons.
Finally, identification of Ac-K123 SOD1 in cells associated with CSF is an interesting finding. AcK123 SOD1 was highly localized to choroid plexus cuboidal cells and ventricle wall ependymal
cells, the cells responsible for CSF production and circulation within the brain. Ac-K123 SOD1
antibody also strongly stained ependymal cells of the central canal within the spinal cord, an
area continuous with the ventricular system of the brain and filled with CSF. Ependymal cells
are responsible for regulating CSF, where interestingly SOD1 has been detected in patients.
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Collectively, our findings provide a new understanding of the regional and cell-specific
distribution of Ac-K123 SOD1 in the central nervous system. PTMs profoundly affect the
structure and function of proteins, and substantial evidence suggests a role for aberrant PTMs
in many neurodegenerative diseases. Significantly, PTMs have been shown to promote SOD1
misfolding in ALS. Because of the critical role of SOD1 and the distribution patterns of Ac-K123
SOD1 within the central nervous system that we have identified, our observations lay the
foundation for future investigations into the function of acetylation in normal physiology and
pathophysiology.

57

CHAPTER THREE: SOD1 ACETYLATION AND THE CELL CYCLE
3.1 Protein acetylation and the cell cycle
Acetylation and deacetylation of proteins is regulated by several families of acetyltransferase
and deacetylase proteins. Among other factors, nutrient availability and cell cycle phase affect
the acetylation status of proteins (Schwer et al., 2009).

3.1.1 SOD1 and the cell cycle
The process of cell proliferation is tightly controlled and highly sensitive to damages resulting
from oxidative stress. To ensure fidelity during cell division, the cell relies on an antioxidant
system to combat reactive oxygen species as well as a surveillance system to detect oxidative
damage and initiate cell cycle checkpoint responses (Shackelford et al., 2000). It has been
shown that SOD1 plays an important role in both these cellular systems. 2
The importance of SOD1 as an antioxidant has been demonstrated by in vivo studies utilizing
Sod1-/- mice. Biochemical analysis of various organs showed an accumulation of oxidative
molecules such as oxidized nucleic acids, lipid peroxidants, and advanced glycation end
products (Watanabe et al., 2014). Data from tissues also shows induction of the DNA damage
response via upregulation and activation of tumor suppressor p53 (Han et al., 2008a). Work in
cultured cells further demonstrated this link with p53, as Sod1 deficient fibroblasts exhibited

This chapter includes material from the article “Primary cilia and autophagic dysfunction in Huntington's disease”
previously published in Cell Death and Differentiation by Nature Publishing Group
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superoxide accumulation which led to p53-mediated growth arrest and apoptosis (Watanabe et
al., 2013). SOD1 has also been shown to take a more direct role with regard to protection of the
genome. A recent report describes how SOD1, in response to ROS, translocates to the nucleus
where it acts as a transcription factor to regulate the expression of oxidative resistance and
repair genes (Tsang et al., 2014). Disturbed intracellular redox signaling and numerous
alterations in the expression or activation of cell cycle proteins have also been described in
various models of ALS involving mutant SOD1 (Cova et al., 2010; Nguyen et al., 2003), further
demonstrating an intricate link between SOD1 and cell cycle regulation.

3.1.2 Structure and function of primary cilia
Found in nearly all post-mitotic or growth-arrested mammalian cells, primary cilia are solitary
structures that protrude into the extracellular environment (Wheatley et al., 1996) (Figure 13AB). These highly conserved, non-motile, signaling organelles act like cellular antennae, receiving
neuroendocrine and sensory signals from the environment and activating signaling cascades
that communicate with the rest of the cell (Singla and Reiter, 2006).
In order to facilitate their specialized signaling functions, primary cilia are compartmentalized
from the rest of the cell by unique structures that include an ordered membrane-bound septin
ring structure, a transition zone at the base of the cilium, and a specialized receptor-dense
ciliary membrane (Garcia-Gonzalo et al., 2011; Hu et al., 2010). A microtubule-based axoneme
extends out from the basal body which is anchored to the plasma membrane by transition
fibers (Figure 13C). A unique bidirectional intraflagellar transport (IFT) system is utilized for the
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trafficking of signaling and structural components along the axoneme (Rosenbaum and
Witman, 2002). A complex of Bardet-Biedl Syndrome proteins (BBSome) and IFT proteins
coordinates cargo attachment to microtubule motors, creating multi-protein IFT complexes that
travel along the axoneme (Wei et al., 2012). IFT complex A is utilized for dynein-2-mediated
retrograde transport and IFT complex B is used for kinesin-2-mediated transport to the ciliary
tip (Figure 13C).
Primary cilia are essential for the regulation of critical signals during embryonic development
and tissue homeostasis. Their presence is required for Sonic hedgehog signal transduction, and
they have essential roles in Wnt, platelet-derived growth factor and transforming growth
factor-β signaling pathways (Clement et al., 2013; Corbit et al., 2005, 2008; Rohatgi et al., 2007;
Schneider et al., 2005). Primary cilia are also essential for mechanosensory signal transduction,
such as in the detection of fluid flow in the kidney epithelium (Nauli et al., 2003; Pazour et al.,
2002). Receptors and signaling cascades essential for olfaction, vision, hearing, and taste are
also localized to primary cilia, demonstrating a key role in sensory perception (Jenkins et al.,
2009; Kulaga et al., 2004; Sun et al., 2012; Wheway et al., 2013; Zhang et al., 2013). Primary
cilia also play important roles in hormonal regulation with implications in dopamine,
somatostatin, serotonin, and leptin signaling (Brailov et al., 2000; Domire et al., 2011; Han et
al., 2014; Händel et al., 1999).
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Figure 13. The primary cilium is a specialized signaling organelle.
A. Schematic of an astrocyte with a primary cilium. B. Fluorescent micrograph of a rat spinal
primary astrocyte expressing dsRed-Centrin 2 (centriole marker) and somatostatin receptor
type III (SSTR3)-GFP (primary cilia marker) that was fixed and stained with Hoechst dye (nucleus
marker). C. Schematic of a primary cilium highlighting compartmentalization from the rest of
the cell by unique structures, including the septin ring, transition zone, and ciliary membrane.
The axoneme nucleates out from the basal body, which is anchored to the plasma membrane
by transition fibers. Signal transduction is mediated by the receptor dense ciliary membrane
and a specialized intraflagellar transport system (IFT) along the axoneme. The primary ciliary
membrane is enriched in membrane receptors that include SSTR3. Cargo transport within the
primary cilium is coordinated by the Bardet-Biedl Syndrome (BBSome) complex, IFT complex A,
and IFT complex B. Figure adapted from Kaliszewski, M., Knott, A. B., & Bossy-Wetzel, E. (2015).
Primary cilia and autophagic dysfunction in Huntington’s disease. Cell Death and Differentiation,
22(9), 1413–1424.
3.1.3 Primary cilia in the nervous system
In the brain primary cilia are evident on virtually all brain cells including progenitors, neurons,
and astrocytes. (Guemez-Gamboa et al., 2014; He et al., 2014).
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Present in neurons, astrocytes and progenitors, primary cilia play important roles in the
nervous system; these include neurodevelopment, neuronal homeostasis, differentiation and
survival (Guemez-Gamboa et al., 2014). Neurological defects associated with ciliopathies, multisystem genetic disorders stemming from primary ciliary dysfunction, underscore the critical role
of primary cilia in the nervous system. Primary cilia also maintain important functions in the
adult nervous system, including neural stem cell regulation, neuronal signaling and
regeneration (Han et al., 2008b). Recently, primary cilia dysfunction has also been implicated in
late-onset neurodegenerative disorders such as Alzheimer’s disease and Huntington’s disease
(Armato, 2012; Chakravarthy et al., 2012; Keryer et al., 2011; Liu and Zeitlin, 2011;
Sotthibundhu et al., 2009).

3.1.4 Primary cilia and the cell cycle
Primary cilia are connected to cell cycle progression and play an important role in regulating
cellular proliferation. These post-mitotic structures only form in quiescent cells, when during
the G0 and G1 phases of the cell cycle the mother centriole moves to the cell membrane where
it differentiates into the basal body, the structure from which the microtubule-based axoneme
extends to form the primary cilium (Tang et al., 2013).
Prior to cell cycle entry and progression, the primary cilium must be disassembled (Ke and Yang,
2014). Ciliary disassembly is regulated by Aurora A kinase, localized at the basal body, which
activates HDAC6 and promotes deacetylation of α-tubulin, ciliary resorption and axoneme
disassembly (Pugacheva et al., 2007). It is the subsequent liberation of the basal body, required
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for reutilization in the formation of the mitotic spindles, that regulates cell cycle re-entry
(Seeley and Nachury, 2010). Recent studies have shown that ciliary length can also influence
cell cycle time. Cells with longer primary cilia exhibit delayed re-entry into cell cycle based on
signaling to the cytosol concerning the length of axoneme (Kim et al., 2011). The involvement
of a ciliary length-based signal in regulation of cell cycle further demonstrates that primary cilia
may function as a structural checkpoint in cell cycle re-entry.
Primary cilia also influence cell cycle through cross talk with autophagy, the major intracellular
degradation system that mediates the turnover and recycling of proteins and organelles
(Baehrecke, 2005). Autophagy occurs at low basal levels to perform homeostatic functions such
as the recycling of damaged organelles. During adverse conditions, such as nutrient deprivation,
induced autophagy acts as a pro-survival mechanism, making it essential for maintenance of
the cell cycle in a nutrient-dependent manner. As environmental sensors of the cell, primary
cilia transmit signals to the cell regarding conditions of the extracellular space that include
information such as growth factor and nutrient availability (Boehlke et al., 2010). In cultured
cells autophagy and primary cilia biogenesis are both triggered upon the growth arrest induced
by nutrient withdrawal (Kiprilov et al., 2008), and recent findings describe a functional
relationship between these pathways.
The induction of autophagy is dependent on Sonic hedgehog (Shh) signaling through the
primary cilium, and primary cilia dysfunction results in impaired autophagy (Pampliega et al.,
2013). Conversely, compromised autophagy alters primary cilia growth and structure. Basal

63

autophagy inhibits primary cilia formation through the degradation of proteins required for
intraflagellar transport and the trafficking of components required for cilium growth (Figure
14A), and blocking autophagy results in enhanced primary cilia growth (Pampliega et al., 2013).
By contrast, induced autophagy targets the specific degradation of the centriolar satellite
protein OFD1 and is required for the formation of primary cilia (Tang et al., 2013) (Figure 14B).
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Figure 14. The functional relationship between primary cilia and autophagy.
A. In the absence of Sonic Hedgehog (Shh), the Patched (Ptc) receptor restricts Smoothened
(Smo) entry into the primary cilium, which results in processing of the transcriptional effector
GLI into its repressor form or targeting for degradation. Autophagy is not induced, OFD1 at
centriolar satellites is not degraded and ciliogenesis is impaired. Basal autophagy degrades
IFT20 when nutrient levels are normal. This reduces trafficking of IFT components to the
pericentriolar material, thus impairing the ciliary transport required for growth of primary
cilia. B. Primary ciliogenesis and autophagy are induced during starvation or periods of lownutrient availability. Autophagy induction is dependent on Shh signaling through the primary
cilium. Shh signal transduction is mediated by Smo, which undergoes localization to the primary
cilium following Shh binding to Ptc. Smo accumulation within primary cilia promotes GLI protein
processing into its transcriptional activator form (GLI-A), enabling downstream signal
transduction. Shh-mediated signal transduction promotes the autophagic degradation of OFD1
at centriolar satellites, which is required for ciliogenesis. Figure adapted from Kaliszewski, M.,
Knott, A. B., & Bossy-Wetzel, E. (2015). Primary cilia and autophagic dysfunction in Huntington’s
disease. Cell Death and Differentiation, 22(9), 1413–1424.
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3.1.5 Histone deacetylase 6
Histone deacetylase 6 (HDAC6) is a predominantly cytoplasmic enzyme that regulates many
important biological processes, including cell migration, formation of the immune synapse,
induction of heat-shock proteins, and clearance of misfolded proteins. HDAC6 is a unique
deacetylase, as it the only member of the deacetylase family that contains two catalytic
domains as well as an ubiquitin-binding domain. The first discovered physiological function of
HDAC6 was the deacetylation of α-tubulin (Hubbert et al., 2002; Matsuyama et al., 2002), a
process that reduces microtubule stability and promotes depolymerization. HDAC6 also
regulates motor protein and cargo recruitment to microtubules and is required for efficient
clearance of misfolded protein aggregates from the cytoplasm (Kawaguchi et al., 2003; Lee et
al., 2010).
Previous studies have shown that HDAC6 plays critical roles in autophagy, apoptosis, and cell
cycle progression (Ding et al., 2013; Pandey et al., 2007). A recent report described mutant
SOD1 selectively interacting with HDAC6 and inhibiting its α-tubulin deacetylase activity (Gal et
al., 2013), yet to date HDAC6 interaction with wild type SOD1 has not been described.

3.1.6 α-Tubulin acetyltransferase 1
α-Tubulin acetyltransferase 1 (αTAT1) is a predominantly cytoplasmic protein and member of
the Gcn5-related N-acetyltransferase superfamily. It is

the major enzyme responsible for

acetylation of α-tubulin at Lys40 (Akella et al., 2010), a modification that is enriched in stable or
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long-lived microtubules such as found within the ciliary axoneme. Tubulin acetylation plays a
conserved role in many microtubule-based processes such as cell locomotion, cell division, and
chemotaxis, and recent evidence shows that α-TAT1 is required for normal assembly of primary
cilia (Shida et al., 2010).

3.2 Materials and Methods
3.2.1 Reagents
Lipofectamine 2000, Tissue protein extraction reagent (TPER), DMEM containing 4500 mg/L Dglucose, GlutaMax-1, N-2 supplement, 100x penicillin/streptomycin, sodium pyruvate, One Shot
fetal bovine serum (FBS), TurboFect transfection reagent, 10% Tween-20 Surfact-Amps
detergent solution, Halt protease and phosphatase inhibitor cocktail, Bolt LDS sample buffer,
Bolt MES sodium dodecyl sulfate (SDS) running buffer, Bolt Bis-Tris Plus 4%–12% gradient gels,
iBlot Gel transfer stacks, iBolt Dry Blotting System, Pierce Western Blotting Substrate, 20 mM
Hoechst 33342 solution, Cytoseal 60, and premium cover glass were all obtained from Thermo
Fisher Scientific. Phosphate buffered saline, pH 7.4 (PBS), EDTA, gelatin from cold water fish
skin 45% in H2O, Triton X-100, Ponceau S solution 0.1% w/v and 5% acetic acid, and poly-Llysine, were obtained from Sigma-Aldrich. EM grade paraformaldehyde was obtained from Ted
Pella Inc. Neutralized bacteriological peptone was obtained from Oxoid. HEPES-free acid, NaCl,
and KCl were obtained from OmniPur/Calbiochem. β-Mercaptoethanol-proteomic grade was
obtained from AMRESCO. CHAPS was obtained from G-Biosciences. Tissue culture dishes (100
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and 145 mm) were obtained from Greiner Bio. Costar cell scrapers were obtained from Corning.
Amersham Hyperfilm ECL high performance chemiluminescence films were obtained from GE
Healthcare Limited. VECTAShield fluorescent mounting medium was obtained from Vector
Laboratories, Inc.

3.2.2 Antibodies
Ac-K123 SOD1 antibodies were custom-made by Yenzym Antibodies. Rabbit polyconal SOD1
(rat) (10011387) was obtained from Cayman Chemical. Mouse monoclonal SOD1 (G-11), rabbit
polyclonal SOD1 (FL-154), and rabbit polyclonal adenylyl cyclase 3 (ACIII) antibodies (C-20) were
obtained from Santa Cruz Biotechnology. Mouse monoclonal α-tubulin (DM1A) and rabbit
monoclonal HDAC6 (D2E5) antibodies were purchased from Cell Signaling. Mouse monoclonal
acetylated α-tubulin (6-11B-1), mouse monoclonal FLAG (M2), and mouse monoclonal MAP2
(HM-2) antibodies were obtained from Sigma. Rabbit polyclonal GFP (ab6556) antibody and
chicken polyclonal glial fibrillary acidic protein (GFAP) antibody (ab4674) was acquired from
Abcam. Peroxidase-conjugated AffiniPure donkey anti-rabbit IgG (H+L), peroxidase-conjugated
AffiniPure donkey anti-mouse IgG (H+L), and Alexa Fluor 594 AffiniPure Fab fragment donkey
anti-rabbit IgG (H+L) secondary antibodies were obtained from Jackson ImmunoResearch
Laboratories, Inc. Alexa Fluor 488 goat-anti-rabbit IgG (H+L), highly cross-absorbed, Alexa Fluor
594 goat anti-mouse IgG (H+L), Alexa Fluor 594-donkey anti-goat IgG (H+L), and Alexa Fluor 647
donkey-anti-chicken IgG (H+L) were obtained from Molecular Probes.
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3.2.3 Mouse embryonic fibroblasts
Mouse embryonic fibroblasts (gift from David Sinclair, Harvard University) were seeded onto
glass coverslips in a 24 well plates at a density of 1 x 105 cells per well and grown in DMEM
supplemented with 4500 mg/L glucose, 10% FBS, 4 mM L-glutamine, 1 mM sodium pyruvate,
and penicillin/streptomycin. For nutrient depletion treatment, growth medium was removed
and replaced with nutrient deprivation buffer (1X HBSS, 10 mM HEPES pH 7.4, 2 mM MgCl 2, 2
mM CaCl2) for 3 hours.

3.2.4 Rats
Timed-pregnant Sprague Dawley rats (Charles River) were used for the isolation of primary
spinal cord astrocytes.

3.2.5 Isolation and transfection of spinal astrocytes
Primary astrocytes were isolated from spinal cords of one litter of E18 embryos from a timedpregnant Sprague Dawley rat (Charles River). Spinal cord tissues were isolated, minced, and
digested in 0.025% trypsin in Earle’s Balanced Salt Solution (EBSS) at 37°C for 20 minutes.
Tissues were transferred into a 50 mL tube containing 45 mL pre-warmed astrocyte medium
(DMEM containing 4500 mg/L D-glucose, GlutaMax-1, N-2 supplement, 10% FBS, and
penicillin/streptomycin) and allowed to sink. After tissues settled, medium was removed and
replaced with 10 mL fresh astrocyte medium. Tissues were then triturated 20 times using a
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P1000 micropipette. All dissociated cells were seeded onto three 75 cm2 Cellgro culture flasks
(Corning) and cultured at 37 °C, 5% CO2. Medium was replaced the next day and astrocytes
were grown until confluent. Upon reaching confluency, astrocytes were trypsinized with 0.25%
trypsin and seeded at 2×105 cells/cm2 onto 12 mm diameter #1 glass coverslips (Chemglass Life
Sciences, Vineland NJ) coated with poly-L-lysine (50 µg/mL in ddH2O). Prior to immunostaining,
confluent astrocytes were treated for 5 hours with either deacetylase inhibitors (10 mM NAM,
1 µM TSA) or vehicle control (DMSO).

3.2.6 Nutrient depletion and recovery of astrocytes
Spinal cord astrocyte cultures were isolated from E18 rat embryos and seeded DIV6 at a density
of 4 x 105 cells onto 12 mm diameter German glass coverslips (Chemglass Life Sciences) precoated with poly-L-lysine. Cells were cultured for 24 hours in astrocyte medium (DMEM
containing 4500 mg/L D-glucose, GlutaMax-1, N-2 supplement, 10% FBS, and
penicillin/streptomycin) within a tissue culture incubator at 37°C in 5% CO2. For nutrient
depletion treatment, astrocyte medium was removed and replaced with nutrient deprivation
buffer (1X HBSS, 10 mM HEPES pH 7.4, 2 mM MgCl2, 2 mM CaCl2) for 1 or 3 hours. For recovery,
starvation buffer was replaced with fresh media and incubated for one hour.

3.2.7 Immunocytochemistry
Cells were fixed in freshly prepared 4% paraformaldehyde in PBS pH 7.4 for 10 minutes at room
temperature followed by 3 five minute PBS washes. Cells were permeabilized in 0.10% Triton X70

100 in PBS pH 7.4 for 10 minutes. Cells were then washed with PBS 3 times for 5 minutes.
Blocking was performed by incubating cells with 1% gelatin from cold water fish in PBS for 30
minutes at room temperature. Incubation with primary antibodies was performed in 1% fish
gelatin in PBS at 4°C overnight in a humidified chamber. Primary antibodies included custommade anti-Ac-K123 SOD1 polyclonal, anti-rat SOD1 rabbit polyclonal, anti-acetylated-α-tubulin
clone 6-11B-1 mouse monoclonal, anti-MAP2 clone HM-2 mouse monoclonal, and anti-glial
fibrillary acidic protein (GFAP). Goat-anti-rabbit Alexa Fluor 488, goat-anti-mouse Alexa Fluor
594, and goat-anti-chicken Alexa Fluor 647 conjugated secondary antibodies (1:250) were
diluted in 1% fish gelatin in PBS and applied to coverslips for 1 hour incubation in the dark at
room temperature. Nuclei were counterstained with 1 µg/mL Hoechst. Controls performed
with omission of the primary antibodies did not reveal significant immunostaining, nor did
incubation with pre-immune serum collected from rabbits prior to immunization. In antibody
preabsorption controls, purified antibody was incubated for two hours at room temperature in
the primary antibody blocking buffer with the acetylated immunizing peptide (VVHE-acKADDLGKGGC) or the unmodified peptide (VVHEKADDLGKGGC). Immediately following
preabsorption, the antibody/peptide mix was used for immunocytochemical staining.
Coverslips were mounted onto Vectashield mounting and sealed onto glass slides with Cytoseal
60.
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3.2.8 Microscopy
Imaging was carried out with a Zeiss LSM 710 Inverted Axio Observer confocal laser scanning
microscope with six laser excitation lines (405, 458, 488, 514, 543, and 633 nm), a 34 channel
QUASAR detector for spectral analysis, and several objectives including a EC Plan-Neofluar 10x
0.3 numeric aperture (NA) air objective, Plan-Apochromat 20x 0.8 NA air objective, EC PlanNeofluar 40x 1.3 NA oil objective, and a Plan-Apochromat 63x 1.4 NA oil objective. Image
acquisition and processing were performed using Zen 2012 software from Zeiss. To visualize
Hoechst 33342, the excitation/emission wavelength was 405/495 nm using the diode laser. For
Alexa Fluor 488, the excitation/emission wavelength was 488/540 nm using the multiline argon
laser. For Alexa Fluor 594, the excitation/emission wavelength was 543/660 nm using a diode
pumped solid state laser plus a QUASAR detector for all emission wavelengths. On average 25 zstacks of 0.5 µm step-size were acquired for 354 µm x 354 µm scaled image size. The z-stacks
were maximally projected and the gamma value adjusted to 0.70−0.85 using the ZEN 2012
software.
For comparison of the mean fluorescent intensities of inhibitor treated astrocytes to the vehicle
control treated astrocytes, the following confocal acquisition settings were maintained for all
conditions:
Alexa Fluor 488 laser =2.0, Pinhole = 1.75, Gain = 535, Digital gain = 1.0, Interval = 0.35
Alexa Fluor 594 Laser = 2.0, Pinhole = 3.62, Gain = 874, Digital gain = 1.0, Interval = 0.35
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3.2.9 Expi293 cells
Expi293F cells were grown in suspension using vent-cap shaker flasks. Initially, 0.3 × 106
cells/mL were seeded in Expi293 Expression Medium and grown in a tissue culture incubator at
37°C in a humidified atmosphere of 8% CO2 in air on an orbital shaker platform rotating at 125
rpm. Cultures were incubated until cell density reached at least 3 × 106 viable cells/mL (typically
3–4 days), at which time transfections are carried out.

3.2.10 Pharmacologic inhibitor treatment against HDAC6
Cells were treated for 6 hrs with either 10 μM Tubastatin A, 10 μM Tubacin, or 0.1% DMSO
(vehicle control). Following inhibitor treatment, HEK293 cells were harvested for western blot
analysis and cultured astrocytes were processed for immunocytochemistry.

3.2.11 HDAC6/α-TAT1 siRNA mediated knockdown
HEK293T cells were seeded into 6 well culture plates in DMEM, high glucose supplemented
with 10% FBS + P/S. At approximately 70% confluency, DNA plasmids and/or siRNA are
delivered into cells by cationic lipid-mediated transfection utilizing Lipofectamine 2000
transfection reagent. For each well to be transfected 5 µl of Lipofectamine 2000 is diluted into
150 µl OptiMEM. In a separate tube, 0.75 µg DNA and/or 20 pmol ON-TARGETplus
SMARTpool™ siRNA against HDAC6, α-TAT1, or scrambled siRNA control is also diluted into 150
µl OptiMEM. After 5 minutes, both solutions are mixed together and incubated for 20 minutes
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at room temperature. The DNA/siRNA lipid complexes are then added dropwise to each well
containing cells in 2 mL growth medium. Transfected cells are thn cultured at 37°C in 5% CO2.
After 48-72 hours cells are washed very gently with PBS to remove serum proteins. Cells are
then harvested with cell scraper, pelleted by a 5 minute centrifugation at 800 rpm, and
resuspended in ice cold lysis buffer (TPER containing Halt protease and phosphatase inhibitor
cocktail, Tubastatin A, TSA, and NAM). Cells were lysed by freezing on dry ice followed by rapid
thaw, followed by one cycle of sonication at 50% output for 20 seconds. Lysates were cleared
by centrifugation at 14,000 x g at 4°C for 10 minutes and total protein concentrations were
determined by a Bradford assay kit.

3.2.12 SOD1 and HDAC6/α-TAT1 overexpression
Expi293F cells were transfected by electroporation using an Amexa Nucleofector system
(Lonza). For each transfection 1x106 cells were resuspended in 100 uL prewarmed
electroporation buffer (12.5 mM NaCl, 123 mM KCl, 20 mM KOH, 10 mM EGTA, 4.5 mM MgCl2,
20 mM PIPES pH 6.9, and 20% FBS) and mixed with 5 ug plasmid DNA in a cuvette. Cells were
electroporated using program Q-01. Immediately after transfection, cells were removed from
cuvette and seeded into 100 mm dish in 10 mL medium and grown for 72 hours.

3.2.13 Immunoprecipitation
1 mg of lysates of Expi293 cells transiently expressing SOD1, SOD1 and HDAC6-FLAG, or SOD1
and α-TAT1-EGFP were incubated with 5 μg of anti-Ac-K123 SOD1, 5 uL anti-FLAG, or 5 uL anti74

GFP antibody overnight. 50 μl of protein G-Dynabeads magnetic beads were added to the
lysates and rotated at room temperature for 1 hour. The immune complexes were collected by
magnet, washed 3 times with lysis buffer, quickly rinsed with ddH2O, and resolved by SDS PAGE
using gradient 4%–12% Bolt Bis-Tris Plus gels. Proteins were transferred to nitrocellulose
membranes using the iBlot western blotting system and probed with anti-Ac-K123 SOD1, antiHDAC6, or anti-GFP antibody.
3.3 Results
3.3.1 Antibodies are specific for K123-acetylated SOD1 by immunocytochemistry
It was important to first show that the Ac-K123 SOD1 antibody does not cross-react with
unacetylated SOD1 when used in immunocytochemistry. Therefore, we performed antibodypeptide pre-incubation experiments using rat primary spinal astrocytes. We found that
antibody preabsorption with the acetylated synthetic immunizing peptide abolished binding. In
the antibody alone condition, we observed immunostaining of Ac-K123 SOD1 antibody in the
nucleus of astrocytes (Figure 15A, column 1). Antibody incubated with acetylated peptide at 1:1
and 1:5 molar ratio blocked immunoreactivity (Figure 15A, columns 2 and 3). Preabsorption
with unacetylated peptide did not block immunoreactivity (Figure 15A, columns 4 and 5).
Finally, antibody incubated with acetylated peptide (1:1) and unacetylated peptide (1:100)
blocked immunoreactivity (Figure 15A, column 6). As a control for experimental conditions, we
also immunostained for total SOD1 using a commercial antibody against SOD1. As expected,
this resulted in diffuse staining of the cytoplasm, identified as the area of the cell surrounding
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the Hoechst counterstained nucleus (Figure 15A, column 7). Quantification of nuclear mean
fluorescence intensity was also performed for three independent experiments (Figure 15B).
Pre-incubation with acetylated peptide blocked antibody recognition while no significant
reduction in signal was observed when antibody was pre-incubated with unacetylated peptide
at high molar excess.
Omission of primary antibody from other samples undergoing immunostaining in parallel also
resulted in the absence of staining. These controls confirm that immunostaining results were
not due to primary antibody binding to substrates other than Lys123 acetylated SOD1 or from
non-specific binding of secondary antibodies. Immunostaining with pre-immune serum (serum
collected prior to injection of Ac-K123 SOD1 immunizing peptides) from the corresponding
rabbit was also performed as a negative control. This resulted in a lack of cellular staining and
demonstrated background staining for the antibody.
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Figure 15. Ac-K123 SOD1 antibodies demonstrate specificity for use in immunohistochemistry
A. Confocal micrographs (scale bar, 20 µm) of primary spinal astrocytes immunostained with
SOD1 or Ac-K123 SOD1 antibody that was pre-incubated with no peptide, acetylated peptide,
unacetylated peptide, or a mixture of acetylated and unacetylated peptide (antibody:peptide
molar rations as shown). Hoechst 33342 nuclear labeling and merged images are also shown. B.
Quantification of antibody preabsorption immunocytochemistry results. Data are reported as
percentage of nuclear mean fluorescence intensity relative to the antibody alone control of 150
(antibody alone), 100 (Ab + Ac-peptide 1:1), 100 (Ab + Ac-peptide 1:5), 100 (Ab + unacetylated
peptide 1:100), 100 (Ab + unacetylated peptide 1:500) and 100 (Ab + Ac-peptide 1:1 +
unacetylated peptide 1:100) astrocytes in three independent experiments (****significance at
P<0.0001 by ANOVA).
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3.3.2 Ac-K123 SOD1 localizes to nucleus and primary cilium in spinal astrocytes
SOD1 is ubiquitously expressed and predominantly found in the cytoplasm of cells. SOD1 also
localizes to the nucleus and mitochondrial intermembrane (Okado-Matsumoto and Fridovich,
2001; Sturtz et al., 2001; Tsang et al., 2014). Interestingly, a recent proteomic study has
identified SOD1 in isolated mammalian primary cilia (Ishikawa et al., 2012). Due to the role of
PTMs in the regulation of subcellular localization of proteins, we investigated whether Ac-K123
SOD1 was preferentially localized to particular regions of the cell. We performed
immunostaining of primary rat spinal astrocytes with either a commercially available SOD1
antibody or our customized antibody against Ac-K123 SOD1.
Immunostaining with commercial SOD1 antibody resulted in diffuse cytoplasmic staining,
identified as the area of the cell surrounding the Hoechst counterstained nucleus (Figure 15A).
Unexpectedly, we found that Ac-K123 SOD1 localized to the nucleus and primary cilium of
cultured rat primary spinal astrocytes (Figure 16A). We identified primary cilia, which are
solitary non-motile microtubule-based signaling organelles protruding from most quiescent or
interphase mammalian cells including neurons and astrocytes (Singla and Reiter, 2006), by costaining with an antibody for Lys40 acetylated α-tubulin, a marker for primary cilia (Figure 16A).
To confirm Ac-K123 SOD1 antibody specificity with regards to the ciliary labeling, primary
astrocytes were immunostained with either untreated Ac-K123 SOD1 antibody or antibody
preabsorbed with the acetylated immunizing peptide. The immunostaining performed with
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preabsorbed antibody resulted in a loss of both nuclear and ciliary staining, demonstrating
antibody specificity to Ac-K123 SOD1 within both the nucleus and primary cilium (Figure 16B).

Figure 16. Ac-K123 SOD1 is localized to the primary cilium and nucleus.
A. Confocal micrograph (scale bar, 10 µm) of primary astrocytes immunostained with
antibodies against Ac-K123 SOD1 and primary cilia marker Ac-K40 α-tubulin. Nuclei are
counterstained with Hoechst 33342 dye. Inset shows a 4.7x zoom of the boxed region
demonstrating Ac-K123 SOD1 and Ac-K40 tubulin co-labeling within the primary cilia. B.
Confocal micrograph (scale bar, 20 µm) of nutrient withdrawn primary astrocytes with
untreated Ac-K123 SOD1 antibody or Ac-K123 SOD1 antibody preabsorbed with the acetylated
synthetic peptide. Nuclei are labeled by Hoechst and Ac-K123 SOD1 labeled primary cilia are
identified (arrow). Inset shows a 2.5x zoom of the boxed region demonstrating abolishment of
ciliary labeling in cells immunostained with preabsorbed Ac-K123 SOD1 antibody.
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3.3.3 Ac-K123 SOD1 localization is dependent on cell cycle phase
The localization of Ac-K123 SOD1 to the nucleus and primary cilium is of particular interest
because of the intimate relationship between these organelles and the cell cycle. The nucleus is
home to cellular DNA in the form of chromosomes, and it must disassemble and reform each
time the cell divides. The primary cilium is unique in that it only forms in resting cells. In fact,
because its axoneme nucleates out from the basal body (a modified mother centriole docked to
the plasma membrane upon cell cycle exit), the primary cilium must retract and disassemble in
order to make both centrioles available for spindle formation and subsequent cell division
(Pugacheva et al., 2007). To investigate Lys123 acetylated SOD1 localization in arrested
astrocytes, we induced cellular quiescence through nutrient deprivation. The total elimination
of nutrients and growth factors reduces basal cellular activity and makes the population of cells
more homogenous as they withdraw from the cell cycle and enter the quiescent G0/G1 phase
(Pirkmajer and Chibalin, 2011).
Our initial study of Ac-K123 SOD1 localization in growth arrested cells employed mouse
embryonic fibroblast cells (MEFs). Cells were cultured in normal growth medium until near
confluency. Once cultures were nearly confluent, serum-containing medium was removed and
replaced with a nutrient deprivation buffer lacking growth factors and nutrients while the
control cells continued being cultured in normal growth medium. After 3 hours MEFs were fixed
and immunostained with our antibody against Ac-K123 SOD1. We found that MEFs grown in
normal medium demonstrated strong nuclear localization of Ac-K123 SOD1 (Figure 17A, upper
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panel). After cell cycle arrest induced by total nutrient deprivation, Ac-K123 SOD1 was no
longer predominantly found within the nucleus but rather in the cytoplasm (Figure 17A, lower
panel). Quantification of the percentage of cells with nuclear Ac-K123 SOD1 from 3
independent experiments shows that growth arrest promotes a significant loss of Ac-K123
SOD1 localization to the nucleus (Figure 17B). Whether the cell cycle arrest of MEFs is
promoting the translocation of Ac-K123 SOD1 from the nucleus to the cytoplasm or the
deacetylation of nuclear SOD1 and acetylation of cytoplasmic SOD1 remains to be determined.
Another key finding from the MEFs immunostaining was that Ac-K123 staining of the primary
cilium is increased after cells underwent nutrient deprivation (Figure 17C). Quantification of
percentage of cells with Ac-K123 SOD1 labeled primary cilia demonstrates that there is a
significant increase from less than 5% of cells under normal conditions to nearly 20% of cells
after nutrient deprivation. Based on these findings, we found that Ac-K123 SOD1 subcellular
localization in MEFs was clearly responsive to the nutritional status of the cell. We next
explored whether this finding extends to primary astrocytes.
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Figure 17. Cell cycle withdrawal decreases nuclear Ac-K123 SOD1 while promoting ciliary
localization in mouse embryonic fibroblasts.
A. Fluorescent micrographs (scale bar, 20 µm) of mouse embryonic fibroblasts immunostained
for Ac-K123 SOD1 with Hoechst nuclear counterstain. Cells were cultured to near confluency
and then subjected to 0 or 3 hours of total nutrient withdrawal. A labeled primary cilium is
marked by an arrow. B. Quantification of percentage Ac-K123 SOD1 nuclear localization in
control versus nutrient depletion conditions shown with standard error of the mean error bars
from three independent experiments (****significance at P<0.0001 by ANOVA). Nuclear AcK123 SOD1 was determined to be present if the intensity of immunostaining was comparable to
or greater than the intensity in the surrounding cytoplasm. C. Fluorescent micrographs (scale
bar, 20 µm) of Ac-K123 SOD1 immunostained mouse embryonic fibroblasts demonstrating
ciliary localization. Cells were cultured to near confluency and then subjected to 0 or 3 hours of
total nutrient withdrawal. D. Quantification of percentage of cells with ciliary Ac-K123 SOD1 in
control versus nutrient depletion conditions shown with standard error of the mean error bars
from three independent experiments (**significance at P<0.01 by ANOVA).
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After removal of normal astrocyte growth medium, primary astrocytes were cultured in a
nutrient deprivation buffer lacking nutrients and growth factors. Astrocytes were then fixed and
the subcellular localization of Lys123 acetylated SOD1 was determined by
immunocytochemistry. Similar to our findings from MEFs, we found that the ciliary localization
of Ac-K123 SOD1 dramatically increased in astrocytes undergoing cell cycle arrest while nuclear
localization decreased (Figure 18A). We also observed a decrease in the nuclear pool of Ac-K123
SOD1 that corresponded to duration of nutrient withdrawal, with astrocytes withdrawn for 3
hours showing less nuclear staining than those withdrawn for 1 hour (Figure 18A). Unlike in
MEFs, Ac-K123 SOD1 localization to the cytoplasm after nutrient deprivation was not observed
in astrocytes. To determine how robust the change in Ac-K123 SOD1 localization was in
response to nutrient availability, we performed a recovery condition where the growth medium
was added back to astrocytes that had undergone 3 hours of nutrient deprivation. Rescuing
astrocytes from non-senescent arrest by returning complete medium lead to rapid retraction of
Ac-Lys123 SOD1 labeled primary cilia and recovery of nuclear staining (Figure 18A). Thus,
nutrient withdrawal evokes selective targeting of Lys123 acetylated SOD1 to primary cilia which
is reversible upon recovery from nutrient withdrawal.
Quantification of our immunostaining results shows there is a significant increase in the
number of cells with Ac-K123 SOD1 localized to the primary cilium after just 1 hour of nutrient
deprivation (Figure 18B). Remarkably, after recovery the percentage of astrocytes with Ac-K123
SOD1 labeled primary cilia decreased back to the baseline levels observed in the control.
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Figure 18. Cell cycle arrest promotes Ac-K123 SOD1 ciliary localization in primary astrocytes.
A. Confocal micrographs (scale bar, 20 µm) of primary astrocytes immunostained for Ac-K123
SOD1 with Hoechst nuclear counterstaining. Cells were cultured to near confluency and then
subjected to 0, 1 or 3 hours of total nutrient withdrawal or 3 hours of nutrient withdrawal
followed by 1 hour recovery with complete growth medium. B. Quantification of percentage of
astrocytes with ciliary Ac-K123 SOD1 in control, nutrient depletion, or nutrient depletion with
recovery conditions is shown with standard error of the mean error bars from three
independent experiments (**significance at P<0.001 by ANOVA).
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Ac-K123 SOD1 ciliary localization is best observed in arrested cells, but is still evident in
astrocytes growing in normal culture medium. Under these conditions the correlation between
ciliary localization and a decreased nuclear pool of Ac-K123 SOD1 is best demonstrated as not
all cells are synchronized in cell cycle arrest. Immunostaining of primary astrocytes growing in
normal medium shows neighboring cells with distinct Ac-K123 SOD1 localization (Figure 19). In
one astrocyte there is a labeled primary cilium and no nuclear staining, while in the neighboring
astrocyte there is significant nuclear Ac-K123 SOD1 localization and no ciliary labeling.

Figure 19. Ac-K123 SOD1 localization to primary cilium correlates to decreased nuclear signal.
Confocal micrograph (scale bar, 10 µm) of neighboring primary astrocytes immunostained with
antibodies against Ac-K123 SOD1 and primary cilia marker Ac-K40 Tubulin. Nuclei are
counterstained with Hoechst 33342 dye.

When mitosis begins chromosomes condense, the nucleolus disappears, the nuclear envelope
dissolves, and mitotic spindle fibers align the chromosomes at the metaphase plate along the
middle of the cell in preparation for chromosome separation. During metaphase of mitosis, Ac-
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K123 SOD1 was closely associated with chromosomes along the metaphase plate in cultured rat
primary spinal astrocytes (Figure 20A). This co-localization of Ac-K123 SOD1 and chromosomes
continues into anaphase as sister chromatids are separated from each other and pulled
towards opposite ends of the cell (Figure 20B). It is also worth noting that during metaphase,
Ac-K123 SOD1 does not co-localize with acetylated α-tubulin comprising the microtubule
polymers that form the mitotic spindle.

Figure 20. Lys123 acetylated SOD1 is associated with chromosomes during mitosis.
A. Confocal micrograph (scale bar, 10 µm) of an astrocyte during metaphase immunostained for
Ac-K123 SOD1 and Ac-K40 α-tubulin with Hoechst counterstaining for DNA. B. Confocal
micrograph (scale bar, 10 µm) of an astrocyte during anaphase immunostained for Ac-K123
SOD1 and Ac-K40 α-tubulin with Hoechst counterstaining for DNA.
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At the end of mitosis, during telophase, chromosomes decondense into diffuse chromatin and
new membranes form around the daughter nuclei. Spindle fibers disperse and the cell proceeds
to cytokinesis, the physical process of cell division. Immunostaining of rat primary spinal
astrocytes shows that Ac-K123 SOD1 was concentrated within the midbody during the end
stage of telophase prior to cytokinesis (Figure 21). The microtubule-based midbody is a
transient structure connecting two daughter cells with the principal function being to localize
the site of abscission during cytokinesis (Hu et al., 2012). Despite the importance of the
midbody, its assembly and regulation is not fully understood. Indeed, the localization of AcK123 SOD1 at the midbody and any potential interactions with microtubule interacting proteins
merits further investigation. And although Ac-K123 SOD1 appears to be absent from the center
of the midbody based on our immunostaining data, this may not be truly representative due to
the presence of an antibody excluding region at the center that makes immunofluorescence
problematic in this region of the midbody (Hu et al., 2012).

Figure 21. Lys123 acetylated SOD1 is concentrated within the transient midbody structure
during the end stage of telophase.
Confocal micrograph (scale bar, 10 µm) of cultured rat primary spinal astrocytes
immunostained for Ac-K123 SOD1 and Ac-K40 α-tubulin.
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In summary, results from the immunostaining of primary astrocyte demonstrate that Ac-K123
SOD1 exhibits specific subcellular localization during the stages of interphase and mitosis
(Figure 22).

Figure 22. Ac-K123 SOD1 localization in astrocytes during specific stages of interphase and
mitosis.
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3.3.5 SOD1 interacts with HDAC6 in cells
We used a candidate approach to evaluate the potential regulators of SOD1 Lys123 acetylation.
Given that HDAC6 and α-TAT1 are predominantly cytoplasmic enzymes, they would have access
to SOD1 for modification. And similar to Ac-K123 SOD1, HDAC6 and α-TAT1 are also associated
with primary cilia. HDAC6 is required for axoneme resorption and primary cilium disassembly
while α-TAT1 promotes axoneme growth and primary cilium biogenesis (Pugacheva et al., 2007;
Shida et al., 2010).
To confirm the interaction between Ac-K123 SOD1 and HDAC6 in cells, an expression vector
encoding human SOD1 was co-transfected with an expression vector for FLAG-tagged human
HDAC6 into Expi293F cells, a modified HEK293 cell line grown in suspension for higher protein
yield. Cells were harvested and lysed 72 hours post transfection. Cell lysates were subsequently
mixed with our anti-Ac-K123 SOD1 polyclonal antibody, which had been raised against the
acetylated K123 of SOD1 protein, and the resulting immune complexes were collected and
analyzed by immunoblotting with anti-FLAG antibody. We found that immunoprecipitation of
Ac-K123 SOD1 from lysates of these co-transfected cells resulted in co-precipitation of HDAC6
(Figure 23). We also detected this interaction reciprocally by using the anti-FLAG antibody for
immunoprecipitation and our anti-Ac-K123 SOD1 antibody for probing of the blotted
precipitate (Figure 23). These observations provided the first indications that Ac-K123 SOD1 and
HDAC6 can form physical complexes with one another in vivo.
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Figure 23. HDAC6 and SOD1 interact in cells.
Co-immunoprecipitations of Expi293 cells transfected with SOD1 WT or SOD1 WT + HDAC6FLAG were performed using Ac-K123 SOD1 or FLAG antibody, and subsequent western blots
were performed using antibodies against Ac-K123 SOD1, FLAG, or α-Tubulin (loading control).
Experimental data from B. Bossy, figure preparation by M. Kaliszewski.
3.3.6 HDAC6 inhibition or knockdown increases SOD1 K123 acetylation
We next assessed whether HDAC6 inhibition can block SOD1 deacetylation in cells. Cultured
spinal cord astrocytes were pre-treated with HDAC6 pharmacological inhibitors tubastatin A
and tubacin or a vehicle control, fixed, and immunostained with our Ac-K123 SOD1 antibody.
Our results showed that both tubstatin A and tubacin potently blocked HDAC6 deacetylation of
SOD1 in astrocytes and resulted in significantly increased immunolabeling of Ac-K123 SOD1
(Figure 24A). Co-labeling with antibodies against Ac-Tubulin demonstrate that Ac-K123 SOD1
detection predominantly within the nucleus. Quantification of the mean fluorescence intensity
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of 3 independent experiments showed that HDAC6 inhibitor treatment resulted in significant
increase in Ac-K123 SOD1 signal, with more than a 4-fold increase in tubastatin A and tubacin
treated cells compared to the vehicle control (Figure 24B). Western blot analysis of Expi293
cells treated with tubastatin A or tubacin also showed increased detection of Ac-K123 SOD1
when compared to vehicle control treated cells (Figure 24C).
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Figure 24. HDAC6 inhibitor treatment increases immunodetection of Ac-K123 SOD1.
A. Confocal micrographs (scale bar 10 μm) of rat primary spinal cord astrocytes treated with
DMSO (control), tubastatin A (10 μM), or tubacin (10 μM) for 6 hours. B. Quantification of
immunostaining data from 3 independent experiments (***, significance of p<0.001 by
ANOVA). C. Western blot analysis of Expi293 cells treated with HDAC6 pharmacological
inhibitors tubastatin A (10 μM), tubacin (10 μM), or vehicle control.
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To confirm the specific effects of HDAC6 inhibition on SOD1 acetylation levels, we used HDAC6
siRNA knockdown in our study. HEK293 cells were co-transfected with a plasmid encoding SOD1
and siRNA targeting HDAC6. Transfected cells were cultured for 72 hours and then analyzed by
western blot. Our results showed increased detection of Ac-K123 SOD1 in cells subjected to
siRNA knockdown of HDAC6 when compared to control cells transfected with SOD1 plasmid
and scrambled siRNA (Figure 25A). Quantification of three independent experiments
demonstrates that HDAC6 knockdown resulted in a significant increase in SOD1 K123
acetylation (Figure 25B).

Figure 25. HDAC6 knockdown increases SOD1 K123 acetylation.
A. Representative western blot of lysate from HEK293 cells transfected with either scrambled
siRNA or siRNA against HDAC6 and probed for Ac-K123 SOD1, SOD1, HDAC6, or α-Tubulin
(loading control). B. Quantification by T-test (n=3, * signifies P value < 0.05). Experimental data
from B. Bossy, quantification and figure preparation by M. Kaliszewski.
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In summary, both pharmacological inhibitor treatment and HDAC6 knockdown inhibited
HDAC6-mediated deacetylation of SOD1 and resulted in increased detection of Ac-K123 SOD1.

3.3.7 Deacetylation of SOD1 by HDAC6 in vivo
Next we proceeded to test the ability of HDAC6 to deacetylate SOD1 in vivo. We used the
Expi293 expression system to transiently express SOD1 alone or in combination with HDAC6,
and then compared the processed lysates by western blot analysis. To gauge the levels of SOD1
acetylation at Lys123, we used our rabbit anti-Ac-K123 SOD1 antibody.
Co-transfection of the SOD1 and HDAC6-FLAG plasmids substantially decreased the acetylated
SOD1 that could be detected by the Ac-K123 SOD1 antibody (Figure 26A) when compared to
SOD1 alone, and quantification of three independent experiments demonstrated a significant
decrease (nearly 75%) of the Ac-K123 SOD1 signal in these samples (Figure 26B) . We therefore
concluded that HDAC6 acts in vivo to specifically reduce the level of the K123 acetylated form
of SOD1.
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Figure 26. HDAC6 deacetylates Ac-K123 SOD1.
A. Western blot of lysate from Expi293 cells transfected with either SOD1 WT or SOD1 WT +
HDAC6 and probed for Ac-K123 SOD1, SOD1, HDAC6, or α-Tubulin (loading control). B.
Quantification (n=3, P value=0.0093). Experimental data from B. Bossy and R. Shaffer,
quantification and figure preparation by M. Kaliszewski.
3.3.8 SOD1 interacts with α-TAT1 in cells
To determine if SOD1 and αTAT1 interacted in cells, Expi293 cells were transfected with
plasmids expressing human SOD1 WT alone or in combination with human αTAT1-EGFP and
analyzed by co-immunoprecipitation. When we performed western blot analysis of the
immunoprecipitation of SOD1, we were able to also detect α-TAT1 (through its GFP tag) from
the lysate of co-transfected cells (Figure 27). We also detected the reciprocal interaction by
using an anti-GFP antibody for immunoprecipitation of α-TAT1 and an anti-SOD1 antibody for
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immunoblotting (Figure 27). These results demonstrate that SOD1 and α-TAT1 can form
physical complexes and interact within the cell.

Figure 27. α-TAT1 and SOD1 interact in cells.
Co-immunoprecipitations of Expi293 cells transfected with either SOD1 WT or SOD1 WT +
αTAT1-EGFP were performed using SOD1 or EGFP antibody, and subsequent western blots
were performed using antibodies against SOD1, EGFP, or α-Tubulin (loading control).
Experimental data from B. Bossy, figure preparation by M. Kaliszewski.
3.3.9 α-TAT1 knockdown decreases SOD1 K123 acetylation
To assess how depletion of α-TAT1 depletion affects the acetylation of SOD1, we examined
Lys123 acetylation in HEK293 cells after siRNA-mediated knockdown of α-TAT1. We found that
α-TAT1 depletion resulted in decreased SOD1 K123 acetylation levels (Figure 28), supporting
our hypothesis that SOD1 is acetylated by αTAT1 in vivo.
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Figure 28. α-TAT1 siRNA mediated knockdown decreases SOD1 K123 acetylation.
Western blot of lysate from Expi293 cells transfected with either scrambled siRNA or siRNA
against αTAT1 and probed for Ac-K123 SOD1, SOD1, or α-Tubulin (loading control). Numbers
beneath the Ac-K123 SOD1 bands represent the relative integrated density values normalized
to total SOD1. Experimental data from B. Bossy, figure preparation by M. Kaliszewski.
3.3.10 α-TAT1 acetylates SOD1 K123
To confirm that α-TAT1 is involved in the in vivo acetylation of SOD1, we evaluated Ac-K123
SOD1 levels in lysates from cells transfected with either SOD1 plasmid alone or in combination
with α-TAT1 plasmid. Western blot analysis showed that Ac-K123 SOD1 detection is increased
in cells co-expressing α-TAT1 (Figure 29A). Quantification of the normalized data from three
separate experiments confirms that we observed an increase of Lys123 acetylated SOD1 in the
cells co-transfected with α-TAT1 (Figure 29B).
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Figure 29. α-TAT1 acetylates SOD1 K123.
Western blot of lysate from Expi293 cells transfected with either SOD1 WT or SOD1 WT +
αTAT1-EGFP and probed for Ac-K123 SOD1, SOD1, EGFP, or α-Tubulin (loading control).
Experimental data from B. Bossy, quantification and figure preparation by M. Kaliszewski.

3.4 Discussion
To date, the effect of SOD1 lysine acetylation on protein localization has not been extensively
characterized. In this study, we employed a custom antibody against acetyl-Lys123 SOD1 (AcK123 SOD1) to examine the subcellular localization of Ac-K123 SOD1 in primary astrocytes and
neurons.
We found that primary astrocytes demonstrated Ac-K123 SOD1 localization to the nucleus and
primary cilium. Interestingly, cellular quiescence promoted a loss of nuclear localization with
increased localization to primary cilia after just one hour of total nutrient deprivation. This rapid
ciliary localization can be explained by two likely scenarios: either Ac-K123 SOD1 is traveling
into the primary cilia or an existing ciliary pool of SOD1 is becoming acetylated. Because the
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primary cilium itself is not present in the majority of cells prior nutrient deprivation, the AcK123 SOD1 immunostaining of primary cilia in arrested astrocytes is most likely due to
translocation. As the ciliary localization of Ac-K123 SOD1 rapidly occurs in parallel to the
formation of primary cilia, it may also be possible that SOD1 has an undiscovered role in
primary cilia biogenesis such as modulating communication between the cilia and cell body or
influencing the IFT-dependent transport of materials required for axonemal growth.
The immunostaining of non-interphase astrocytes also yielded interesting results. We found
that Ac-K123 SOD1 remains associated with the DNA during mitosis. This is an interesting
observation because most contents of the nucleus are released into the cytoplasm following
breakdown of the nuclear envelope. Rather than diffusing into the entire cytoplasm, Ac-K123
SOD1 remains close to the chromosomes. This finding raises the following question: does
acetylated SOD1 play a role in mitosis, possibly aiding chromosome alignment, kinetochore
attachment, or chromatid separation to daughter cell nuclei? SOD1 has been shown to directly
interact with DNA in a transcription factor-like manner in response to oxidative stress (Tsang et
al., 2014), but other roles outside of transcriptional regulation have yet to be described.
It is important to note that our analysis of Ac-K123 SOD1 localization within primary astrocyte
cultures was performed in cells derived from spinal cords of Charles River Spraque-Dawley rats.
This distinction is important, as previous studies have shown that the response to starvation of
primary astrocytes varies based on the rat substrain. When compared to Charles River SpraqueDawley rats, primary astrocytes derived from Harlan Spraque-Dawley rats showed a greater cell
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response to starvation and more similarity to human astrocytes (Codeluppi et al., 2011).
Therefore, it may be beneficial to explore if this rat substrain-dependent difference in response
to nutrient deprivation extends to more pronounced ciliary and nuclear localization of Ac-K123
SOD1.
One key result from our custom antibody immunocytochemical staining experiments is the
nuclear localization of Ac-K123 SOD1 in astrocytes. SOD1 localization and function within the
nucleus has been previously described. Specifically, in response to elevated levels of reactive
oxygen species, SOD1 translocates to the nucleus, binds to promoters, and regulates the
expression of oxidative resistance and repair genes (Tsang et al., 2014). However, our finding
that this nuclear pool of SOD1 is highly acetylated is novel. Acetylation of K123 may play a role
in SOD1 translocation to the nucleus or it may act in retaining it there. Acetylation of K123 may
also alter SOD1 interaction with other proteins or with DNA. Based on findings in other
proteins, it is likely that K123 acetylation promotes the translocation of SOD1 into the nucleus.
An example of a protein undergoing acetylation-mediated translocation is the glycolytic enzyme
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), where upon acetylation the
predominantly cytoplasmic GAPDH undergoes translocation to the nucleus to regulate
transcription and DNA repair (Ventura et al., 2010). It will be interesting to determine if SOD1
acetylation plays a role in the translocation of itself or other proteins, as studies have
demonstrated nucleocytoplasmic transport dysfunction in motor neurons of ALS mouse models
and patients (Kinoshita et al., 2009; Zhang et al., 2006). If Ac-K123 SOD1 does indeed have a
physiological role in the nuclear transport of SOD1 or other proteins, the next step would be to
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determine if there is a link between SOD1 K123 acetylation and the aberrant protein
accumulation observed in ALS.
Another interesting finding from our primary astrocyte immunostaining was the localization of
Ac-K123 SOD1 to primary cilia. To date very little is known with regards to SOD1 and primary
cilia, and our data is the first evidence linking SOD1 acetylation to ciliary localization. This raises
important questions, such as: what is the function of SOD1 K123 acetylation within the primary
cilium, and where (in the cell) does SOD1 acetylation occur? The subcellular location is
important, because SOD1 acetylation may act as a localization signaling domain, mediating
translocation to the primary cilia, or it may behave as a ciliary retention signal, keeping SOD1
within the primary cilium. These are important questions that need to be addressed in future
investigations, and the findings from such studies will help us better understand how posttranslational modification regulates SOD1 subcellular localization. And based on the continued
discovery of new roles for SOD1 within the cell, further inquiry into SOD1 acetylation may
reveal previously unknown cellular functions of SOD1.
The localization of Ac-K123 SOD1 to primary cilia may be significant to ALS pathogenesis.
Primary cilia number is reduced in motor neurons from mutant SOD1 ALS mice (Ma et al.,
2011). There is also evidence that mutant SOD1 disrupts primary cilia-mediated signaling, as
Sonic hedgehog agonist treatment confers neuroprotection in a cellular model of ALS (Peterson
and Turnbull, 2011). With these points in mind, the relationship between disrupted primary
cilia function in ALS and the ciliary localization of Ac-K123 SOD1 merits further investigation.
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It is worth noting that in our present study we have focused exclusively on the subcellular
localization of wildtype SOD1. This is an important point because previous studies have shown a
low nuclear presence of endogenous SOD1 in mouse brain and spinal cord, with higher levels of
SOD1 nuclear accumulation observed in SOD1 WT and ALS mutant transgenic mice (Gertz et al.,
2012). Recent findings from another group describe levels of mutant SOD1 as lower than those
of wildtype SOD1 within the nuclei of both cortical neurons and astrocytes derived from
transgenic mice (Lee et al., 2015). Taken together, it will be of interest to next explore how
acetylation impacts the localization of mutant SOD1 in neurons and astrocytes.
The other goal of this study was to evaluate the potential regulators of SOD1 Lys123
acetylation. Based on our novel immunocytochemical findings that demonstrated Ac-K123
SOD1 localization with the primary cilium, we used a candidate approach to come up with
potential acetyltransferases and deacetylases that have known associations with both the
cytoplasm and primary cilia. We showed that α-TAT1 interacts with and acetylates SOD1 within
cells, while HDAC6 is responsible for the deacetylation of Ac-K123 SOD1. Interestingly,
depletion or dysfunction of both α-TAT1 and HDAC6 are implicated in several disease
processes, including neurodegenerative disorders. It will therefore be of interest to examine
whether aberrant SOD1 acetylation is linked to cellular toxicity. Given that SOD1 misfolding
plays a major role in ALS pathogenesis, an investigation of how Lys123 acetylation impacts
SOD1 structure and stability will be highly merited.
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CHAPTER FOUR: SOD1 LYS123 ACETYLATION PROMOTES
MISFOLDING AND CILIARY TARGETING
4.1 SOD1 and ALS
4.1.1 Overview of ALS
Amyotrophic lateral sclerosis (ALS) is a disease of the motor neurons in the spinal cord, brain
stem, and motor cortex that control voluntary muscle movement. Progressive degeneration of
these motor nerves leads to progressive muscle weakness, atrophy, paralysis, and eventually
death by respiratory failure. ALS is incurable and patient treatment remains primarily palliative.
The glutamate antagonist Riluzole, the only drug approved for the treatment of ALS, has a small
effect on disease progression and extends the median survival by 2–3 months (Bensimon et al.,
1994).
The onset of disease is typically in midlife (between 45 and 60 years of age) with a median
survival period of 3 years after onset of symptoms (Hardiman et al., 2011). The incidence, or
frequency of new cases per year, is 1–2 per 100,000 and the prevalence, or proportion of
affected individuals in the population, is 4–6 per 100,000. Unfortunately, these epidemiologic
statistics understate the true impact of ALS. A better indicator of one’s risk to develop ALS is the
estimated lifetime risk, which is about 1 in 350 in men and 1 in 450 in women (Alonso et al.,
2009).
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The vast majority of ALS cases (approximately 90%) are sporadic (SALS) and of unknown
etiology. The remaining 5-10% of cases are due to inheritable, mostly autosomal dominant,
genetic mutations and are classified as familial ALS (FALS).
Mutations within a wide variety of genes have been implicated in FALS. Important genes
involved in ALS include SOD1, TAR DNA-binding protein 43 (TDP43), fused in
sarcoma/translocated in liposarcoma (FUS), dynactin, optineurin, ubiquilin 2, and a repeat
expansion within the non-coding region of the open reading frame 72 of chromosome 9p
(C9ORF72) (DeJesus-Hernandez et al., 2011; Deng et al., 2011; Kwiatkowski et al., 2009;
Maruyama et al., 2010; Münch et al., 2004; Neumann et al., 2006; Rosen et al., 1993; Vance et
al., 2009).
To date, over 180 mutations identified in SOD1 have been found to cause ALS, accounting for
about 20% of inherited cases (http://alsod.iop.kcl.ac.uk). At least 75 of the 153 amino acids in
SOD1 are mutated and there are no mutational hot spots (Saccon et al., 2013). Mutations are
scattered throughout the protein and can be found within the beta-barrel, the dimer interface,
and the active site channel.

4.1.2 SOD1 toxic gain of function
Due to its important function of protecting the cell from oxidative damage, it was initially
proposed that loss of SOD1 activity may contribute to the pathogenesis of SOD1-linked ALS.
Several key findings from previous investigations have resoundingly put this theory to rest. In
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vitro studies showed that several SOD1 mutant proteins have diminished enzymatic activities,
while at least some mutants linked to ALS retain full enzyme activity (Borchelt et al., 1994). In
mice, the expression of mutant human SOD1 in transgenic mice causes motor neuron disease,
while the expression of wild type human SOD1 does not (Bruijn et al., 1998; Gurney et al.,
1994). And most importantly, Sod1 -/- mice do not develop motor neuron disease (Reaume et
al., 1996). These important findings support the hypothesis that mutant SOD1 toxicity arises
from a gain of function as opposed to a loss of function.
The toxic properties of mutant SOD1 are believed to arise from mutation-induced
conformational changes that cause misfolding and aggregation. Inherited SOD1 mutations
promote structural instability, unfolding, and dimer dissociation; changes that are enhanced by
the release of zinc. Conformational changes alter configuration of the active site channel and
allow non-conventional substrates to interact with copper. As a result mutant SOD1 is more
prone to aberrant redox chemistry, such as the interaction of peroxynitrite or hydrogen
peroxide with reduced copper that results in SOD1 tyrosine nitration and hydroxyradical
formation (Beckman et al., 1993; Wiedau-Pazos et al., 1996). The backward catalysis of
molecular oxygen generates superoxide anions after the loss of zinc, and zinc-defiecient SOD1 is
sufficient for inducing apoptosis in cultured motor neurons (Estévez et al., 1999).
Mutant SOD1 also demonstrates altered subcellular localization and has been identified within
the nucleus, mitochondria, endoplasmic reticulum (ER), Golgi, peroxisomes, and cytoplasm. The
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selective loss of motor neurons reflects a disturbance of several different pathways, and many
pathologic processes attributed to ALS pathogenesis are mediated by mutant SOD1.
Several lines of evidence indicate mutant SOD1-mediated mitochondrial dysfunction. Mutant
SOD1 displays and increased tendency to localize within mitochondria, and abnormal
mitochondrial morphology and cristae vacuolization are observed in ALS patient samples and
mouse models (Kong and Xu, 1998; Wong et al., 1995). Mutant SOD1 blocks mitochondrial
protein import through inhibition of the translocator outer membrane (TOM) complex,
diminishes ATP production by impairing respiration, promotes the release of free calcium, and
decreases the calcium buffering capacity (Damiano et al., 2006; Israelson et al., 2010; Li et al.,
2010; Mattiazzi et al., 2002). Mutant SOD1 alters mitochondrial dynamics, with evidence from a
variety of cellular models demonstrating increased mitochondrial fragmentation and impaired
mitochondrial transport along axons (De Vos et al., 2007; Magrané et al., 2009, 2014; Song et
al., 2013). Additionally, the mitochondrial localization of mutant SOD1 contributes to activation
of the apoptotic pathway. On the mitochondrial surface SOD1 aggregates inhibit the antiapoptotic BCL2 protein and cause damage to the membrane, resulting in cytochrome c release
and caspase activation (Kirkinezos et al., 2005; Pedrini et al., 2010).
Glutamate-induced excitotoxicity is a component of ALS that is caused by the failure to remove
glutamate from synaptic clefts. This results in excessive stimulation of postsynaptic glutamate
receptors and massive calcium influxes into the cell. Motor neurons exhibit a selective
vulnerability to glutamate-induced excitotoxicity due to a diminished capacity to buffer calcium
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and their expression of AMPA ( -amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)/kainate
receptors. Unlike NMDA (N-methyl-D-aspartate) receptors that are utilized by most neurons,
AMPA/kainate receptors lack the GluR2 subunit that regulates calcium permeability and influx
during glutamate stimulation. It has also been reported that mutant SOD1 increases the
expression and function of AMPA receptors, further increasing motor neuron sensitivity to
glutamate-induced toxicity (Spalloni et al., 2004). Additionally there is diminished expression of
the excitatory amino acid transporter 2 (EAAT2) glutamate transporter in mutant SOD1
astrocytes (Howland et al., 2002), further exacerbating the excessive accumulation of glutamate
observed in ALS.
Another characteristic of ALS is abnormal axonal transport, which has been described in both
patients and transgenic mouse models (Sasaki and Iwata, 1996; Sasaki et al., 2005). With axons
that can extend up to one meter in length, motor neurons depend on a functional axonal
transport system for maintaining synaptic function, neurotransmitter release, vesicle recycling,
and mitochondrial calcium buffering. Mutant SOD1 interaction with microtubule motor protein
complexes has been shown to perturb anterograde and retrograde axonal transport (Shi et al.,
2010; Ström et al., 2008), and it has been proposed that impaired axonal transport is an early
event mediating the toxicity of ALS-linked SOD1 mutants in motor neurons (Williamson and
Cleveland, 1999).
Proteasome dysfunction and defective removal of toxic proteins are also features of ALS.
Aggregated SOD1 has been shown to inhibit both chaperone and proteasome activity, resulting
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in the subsequent misfolding and insufficient clearance of other toxic proteins (Bendotti et al.,
2012; Urushitani et al., 2002). Mutant SOD1 also interacts with unfolded protein response
components and is recruited to the ER, adversely effecting ER function and causing sustained
ER stress (Atkin et al., 2006; Kanekura et al., 2009; Wang et al., 2011a).

4.1.3 Misfolding of modified wild-type SOD1
It has recently been suggested that misfolded wild-type SOD1 plays a role in the more
prevalent, sporadic form of the disease (SALS) (Bosco et al., 2010; Rotunno and Bosco, 2013). In
transgenic mice the onset of paralysis is accelerated when wild type SOD1 is co-expressed with
mutant SOD1 (Wang et al., 2009). Evidence from mice shows wild-type SOD1 was induced to
aggregate with mutant SOD1 (Prudencio et al., 2009a), demonstrating wild type SOD1 as a
potential pathogenic link between FALS and SALS. Oxidation, an exogenous post-translational
modification (PTM) of wild-type SOD1, promotes misfolding of the protein (Rakhit et al., 2002),
hinting at the possibility that endogenous PTMs might similarly contribute to misfolding and
SOD1-mediated toxicity in SALS.

4.1.4 Conformation specific misfolded SOD1 (C4F6) antibody
The anti-misfolded SOD1 (C4F6) antibody is conformation specific and is widely used in studies
to identify misfolded SOD1. Studies have shown that the C4F6 monoclonal antibody, which was
produced using standard procedures after immunization of mice with mutant SOD1 G93A
recombinant protein, recognizes epitopes normally buried in the native conformation of SOD1.
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C4F6 antibody shows strong immunoreactivity to SOD1 mutants with little to no reactivity to
wildtype SOD1 (Urushitani et al., 2007). A recent study showed that C4F6 recognizes wild type
SOD1 modified by in vitro oxidation, and furthermore linked wild type SOD1 to SALS by showing
C4F6 immunoreactivity to spinal motor neurons in SALS patients (Bosco et al., 2010). For these
reasons we employed the C4F6 antibody during our investigation into the relationship between
SOD1 acetylation and misfolding.

4.1.5 ALS and non-cell autonomous toxicity
Although the selective degeneration and death of motor neurons is a defining feature of ALS,
recent studies have shown that non-neuronal cells also contribute to the pathogenesis of ALS
(Boillée et al., 2006a). Neuroinflammation arising from activated glial cells and infiltrated
immune cells has been described in both mutant SOD1 mouse models and ALS patients (Endo
et al., 2015; Engelhardt et al., 1993). Moreover, the selective reduction of mutant SOD1
expression in microglia or astrocytes has been shown to significantly extend the survival time of
ALS mice (Beers et al., 2006; Boillée et al., 2006b; Wang et al., 2011b; Yamanaka et al., 2008).

4.1.6 Prion-like spreading of SOD1 in ALS
Increasing evidence supports a model of neurodegenerative disease in which pathological
progression is driven by the formation of aberrant protein aggregates that are propagated in a
self-templating manner. This process resembles the replication of infectious prions, and is
therefore often referred to as “prion-like” protein seeding and propagation (Goedert et al.,
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2010). The prion theory of neurodegeneration postulates that fibrillary protein seeds taken up
by neighboring cells in the brain or spinal cord induce the aggregation of normally structured
proteins, resulting in the spreading of misfolded proteins (Frost and Diamond, 2010). Most
neurodegenerative diseases are characterized by dysfunction in discrete brain regions during
the early stages with more widespread dysfunction in later stages, suggestive of a spreading
pathology (Frost and Diamond, 2010). Furthermore, spreading of protein aggregates has been
shown to mirror the overall clinical pathophysiology of neurodegeneration (Frost and Diamond,
2010).
Mechanistically, the prion-like theory postulates that ALS pathological progression is driven by
the formation of aberrant SOD1 aggregates which are propagated in a self-templating manner
(Figure 30). Misfolded SOD1 acts as seeds of aggregation that sequester and convert natively
folded SOD1 to form growing fibrils. Subsequent fragmentation amplifies the misfolded SOD1
seeds available for repetition of the cycle. The release of seeds into the extracellular
environment and uptake by neighboring cells represents a mechanism of cell-to-cell transfer,
and seeded nucleation within the new cell furthers the repetition of the propagation cycle. The
characteristics of a prion-like spreading mechanism are observed during the progression of ALS
and apply to SOD1.
Clinical observations and mouse model studies describe a contiguous spreading of the disease
that can be explained by propagation of misfolded protein via a prion-like mechanism. Typically,
a focal onset of motor weakness (in the spinal cord and bulbar regions) is followed by regional
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spreading of motor symptoms with exacerbation of local motor symptoms (Ravits, 2014). This
pattern of disease progression suggests that the pathology is propagating neuroanatomically,
starting discretely within one area of the neuraxis and then spreading outward to contiguous
regions. Furthermore, when also taking into consideration the non-cell autonomous nature of
ALS, it is possible that such a spreading mechanism underlies the toxic interplay between
astrocytes and motor neurons.
Another feature of ALS supporting a prion-like spreading is the presence of fibrillary protein
aggregates that can act as structural templates for converting SOD1 from a native to misfolded
protein. Mutant SOD1 aggregation has been demonstrated in human tissues, mouse models,
cultured cells, and in vitro with purified proteins. Spinal cords from ALS patients and FALS
mouse models are characterized by SOD1-positive inclusions within neurons and glial cells
(Bruijn et al., 1998; Chia et al., 2010; Kato, 2007; Matsumoto et al., 1996; Shibata et al., 1994).
Perhaps the most important feature of ALS, with regards to prion-like spreading, is the actual
cell-to-cell transmission and propagation of misfolded proteins. Several cell culture studies
investigating this process showed misfolded SOD1 aggregates promoted further misfolding and
transmission to neighboring cells (Grad et al., 2014; Münch et al., 2011). Interestingly, seeding
of cell cultures with mutant SOD1 aggregates also resulted in misfolding of endogenous
wildtype SOD1 (Münch et al., 2011; Silverman et al., 2016). Furthermore, this aggregation was
self-perpetuating and continued for many passages following removal of aggregate seeds from
the culture medium. In an astrocyte and motor neuron mixed culture study exosomes derived
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from astrocytes were shown to effectively transfer mutant SOD1 to motor neurons and induce
selective cell death (Basso et al., 2013), demonstrating that mutant SOD1 expression in
astrocytes impacts protein secretion pathways and the spread of disease. Recently, in vivo
transmission of mutant SOD1 has been demonstrated in a study using mouse models. Motor
neuron disease was induced by injection of mutant SOD1 spinal cord homogenate into the
spinal cords of unaffected animals (Ayers et al., 2014), providing the first evidence of misfolded
SOD1 intra-organismal transmission.

Figure 30. Model of the prion-like transfer of misfolded SOD1.
4.1.7 Evidence of vesicle secretion from primary cilia
There has been several findings supporting the notion that primary cilia may participate in the
intercellular transfer of materials. One recent study showed that primary cilia of adjacent cells
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contact and form adhesions, allowing for a direct communication between two neighboring
cells (Ott et al., 2012). Although the secretory capabilities of primary cilia in humans remain
uncertain, several lines of evidence suggest that cilia might act as secretory organelles.
Studies of simple organism model systems have identified release of extracellular vesicles from
ciliary structures. EM analysis showed that distal ends of the primary cilia-like flagella of
Chlamydomonas, a unicellular green alga, secrete bioactive vesicles containing a proteolytic
enzyme (Wood et al., 2013). This finding is of potential relevance to human primary cilia
because green algae flagella have traditionally served as a reliable model of mammalian cilia;
other ciliary components first identified in algae and later found to be conserved in mammals
include the IFT proteins (Avasthi and Marshall, 2013; Wood et al., 2013). In addition, ciliated
sensory neurons in Caenorhabditis elegans were recently shown to release extracellular vesicles
(Wang et al., 2014). A recent study of the developing central nervous system in vertebrates also
described membrane budding from primary cilia. Using high-resolution live-cell imaging of chick
neural tube, investigators elegantly describe a form of cell remodeling in which constriction and
abscission of the apical membrane is used for dismantling of the primary cilium and termination
of Shh signal transduction (Das and Storey, 2014).
Early studies in mammalian cells have also yielded indicators of protein secretion from primary
cilia. For example, a study of neuroepithelial cells found that the distribution of prominin-1, a
stem cell marker, on primary cilia was suggestive of budding of small membrane vesicles from
the tips of differentiating cells (Dubreuil et al., 2007). In addition, extracellular membrane
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particles released into neural tube fluid from neuroepithelial cells were found to be enriched in
prominin-1. In humans, the protein contents of exosome-like vesicles purified from urine
suggested that these structures originated from primary cilia (Chacon-Heszele et al., 2014).
In summary, the observations in simpler organisms and recent evidence from mammalian
studies demonstrate that the primary cilium represents a novel source of extracellular
membrane vesicles. Further exploration of primary cilia-mediated protein secretion is therefore
highly warranted, especially when taking into consideration the prion-like propagation of
misfolded SOD1 underlies the pathology of ALS. In light of the clues suggesting protein
secretion from primary cilia, we speculate that primary cilia are important, as yet unexplored
mediators of prion-like spreading of SOD1 in ALS.

4.1.8 Genes linking primary cilia to ALS
Genetic studies, including whole-exome analyses of familial ALS cases, have identified genetic
factors contributing to ALS. Many of the identified genes are structurally or functionally critical
to primary cilia.
Point mutations within the DCTN1 gene encoding the microtubule motor adapter protein
dynactin causes defective transport and is a risk factor for ALS (Münch et al., 2004). Although
dynactin does not interact with cytoplasmic dynein 2, the IFTB motor in primary cilia, it plays an
important role in primary cilia dynamics through the dynein-dynactin complex-dependent
recruitment of the Plk1 kinase to pericentriolar matrix for activation of HDAC6.
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An exome-wide rare variant analysis identified TUBA4A mutations with FALS. Microtubules
comprise the axoneme structure of primary cilia. TUBA4A mutants destabilize microtubules and
diminish their repolymerization capability (Smith et al., 2014).
Studies examining OPTN mutations in ALS patients suggest that optineurin is involved in the
pathogenesis of ALS (Maruyama et al., 2010). Optineurin is an autophagy adapter that interacts
with Rab8 to mediate endocytic trafficking. Optineurin also plays an important role in ciliary
membrane expansion and fusion with the plasma membrane during ciliogenesis.
Mutations within UBQLN2 have also been shown to cause ALS (Deng et al., 2011). The encoded
ubiquilin 2 protein associates with both proteasomes and ubiquitin ligases to modulate in vivo
protein degradation. Due to its important role in linking the ubiquitination machinery to the
proteasome, ubiquilin 2 plays an important autophagic role functionally downstream of the
primary cilia mediated Shh signaling required for induced autophagy. Another mutated protein
functionally related to primary cilia is the actin-binding protein profilin-1. Exome sequencing
demonstrated that PFN1 mutations cause FALS (Wu et al., 2012). Profilin-1 plays an important
role in axon elongation through Shh pathway activation via the primary cilia.
The expanded hexanucleotide repeat within a noncoding region of chromosome 9 open reading
frame 72 (C9ORF72) represents the most common cause of ALS to date (DeJesus-Hernandez et
al., 2011). Although the protein has yet to be fully characterized, initial studies have suggested
a role in endosomal trafficking and autophagy. Structural homology also suggests the C9ORF72
protein is a Rab GEF which activates Rabs. There is also indications that C9ORF72 interacts with
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the primary cilia-associated Rab8, thereby regulating transport to primary cilia, playing a critical
role in early cilia formation, and maintaining ciliary function through coordination with the
intraflagellar transport system.
Interestingly, a recent study involving the screening of whole-exome sequencing data
described the association of NEK1 variants with ALS at exome-wide significance (Kenna et al.,
2016). NEK1 is a kinase linked to several cellular functions, including primary cilia formation.
4.2 Materials and Methods
4.2.1 Reagents
Neurobasal medium, Neuronal Supplement 21, GlutaMAX, 100x penicillin-streptomycin
solution, Lipofectamine 2000, MagnaBind Protein G magnetic beads, and Expi293 Expression
Medium were acquired from Thermo Fisher. Phosphate buffered saline, pH 7.4 (PBS), EDTA,
Tubastatin A hydrochloride, gelatin from cold water fish skin 45% in H2O, Ponceau S solution
0.1% w/v and 5% acetic acid, and poly-L-lysine were obtained from Sigma-Aldrich. Amaxa
Nucleofector kits for rat neurons and rat glial cells were purchased from Lonza.

4.2.2 Antibodies
Ac-K123 SOD1 antibodies were custom-made by Yenzym Antibodies. Mouse monoclonal
misfolded SOD1 (C4F6) antibody was obtained from MédiMabs. Mouse monoclonal SOD1 (G11)
antibody was purchased from Santa Cruz Biotechnology. Mouse monoclonal acetylated αtubulin (6-11B-1) antibody was obtained from Sigma. Peroxidase-conjugated AffiniPure donkey
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anti-rabbit IgG (H+L) and peroxidase-conjugated AffiniPure donkey anti-mouse IgG (H+L)
secondary antibodies were obtained from Jackson ImmunoResearch Laboratories, Inc. Alexa
Fluor 488 goat-anti-rabbit IgG (H+L), highly cross-absorbed, and Alexa Fluor 594 goat antimouse IgG (H+L) were obtained from Molecular Probes.

4.2.3 Rats
Timed-pregnant Sprague Dawley rats (Charles River) were used for the isolation of primary
spinal astrocytes and cortical neurons.

4.2.4 Site directed mutagenesis
Mutagenesis was performed using the QuikChange Lightning site-directed mutagenesis kit
(Agilent Technologies, Santa Clara, CA). The SOD1 K123Q and SOD1 K123R mutants for
mammalian expression were created using the pcDNA3.1 SOD1 WT vector (gift from Dr. Alvaro
Estevez, University of Central Florida) as a template. The primers utilized for mutagenesis were
as follows:
Table 2. The primers used for mutagenesis of SOD1 K123.
Primer
K123Q Forward
K123Q Reverse
K123R Forward
K123R Reverse

Sequence
5’-GCACACTGGTGGTCCATGAACAAGCAGATGACTTGGGC-3’
5’-GCACAAGTCATCTGCTTGTTCATGGACCACCAGTGTGC-3’
5’-GCACACTGGTGGTCCATGAAAGAGCAGATGACTTGGGC-3’
5’-GCCCAAGTCATCTGCTCTTTCATGGACCACCAGTGTGC-3’
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The DNA template-primer mix was amplified using an Eppendorf Mastercycler Gradient 531
PCR machine. After PCR amplification, template DNA was digested by incubation with DpnI at
37oC for 5 minutes. For bacterial transformation, 22.5 µL of XL10-Gold Ultracompetent bacteria
were incubated with 2 µL of PCR-amplified DNA on ice for 30 minutes, heat-shocked at 42o C for
30 seconds, and placed back on ice for 2 minutes. Bacteria were then resuspended in 500 µL
pre-warmed super optimal broth (SOB) (0.5% yeast extract, 2% tryptone, 10 mM NaCl, 2.5 mM
KCl, 20 mM MgSO4) and then grown for one hour at 37o C in a bacterial shaker at 225 rpm.
Finally, 200 µL was plated on LB agar plates containing 100 µg/mL ampicillin. After 37°C
overnight incubation, single colonies were picked and inoculated in 5 mL LB medium with
ampicillin (100 µg/mL). Bacterial cultures were grown overnight at 37 o C in a bacterial shaker at
225 rpm. Plasmid DNA was isolated using a QIAprep Spin Miniprep kit and subjected to DNA
sequencing to confirm mutagenesis (Eurofins Scientific). Large-scale endotoxin-free plasmid
DNA was isolated using a Gene Jet Plasmid Maxiprep kit per manufacturer’s instructions.

4.2.5 Expi293 cells
Expi293F cells were grown in suspension using vent-cap shaker flasks. Initially, 0.3 × 106
cells/mL were seeded in Expi293 Expression Medium and grown in a tissue culture incubator at
37°C in a humidified atmosphere of 8% CO2 in air on an orbital shaker platform rotating at 125
rpm. Cultures were incubated until cell density reached at least 3 × 106 viable cells/mL (typically
3–4 days), at which time transfections are carried out using the ExpiFectamine 293 transfection
kit per manufacturer’s guidelines.
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4.2.6 Immunoprecipitation and western blotting
Expi293F cells were harvested by centrifugation, resuspended in ice cold lysis buffer (TPER
supplemented with protease, phosphatase, and deacetylase inhibitors), and lysed by freezethaw lysis and one cycle of sonication at 50% output for 30 seconds. 1 mg of lysate was mixed
with 5 µg of antibody and rotated overnight at 4°C. Antibody-peptide complexes were then
incubated with 25 µl of MagnaBind Protein G magnetic beads for 1 hour at room temperature
under rotation. Immune complexes were isolated by magnet, washed 3 times in lysis buffer,
quick rinsed one time in ddH2O. Proteins were eluted from beads by boiling in SDS sample
buffer, and collected eluate was removed and loaded onto gels for SDS-PAGE analysis.

4.2.7 Primary cortical neurons and transfection
Cortical neuronal cultures were prepared from embryonic day E18 rat embryos and seeded in
D10C medium. After 4 hours the medium is changed to neuronal medium (Neurobasal medium
supplemented with 2% Neuronal Supplement 21, 2 mM GlutaMAX, and
penicillin/streptomycin).
Primary cortical neurons were isolated from fetal rat cortices dissected and prepared from one
litter of E18 Sprague Dawley rat embryos. For expression of DsRed2-Mito (Clonetech) in
combination with SOD1 WT or one of the various SOD1 mutants, cortical neurons were
transfected by electroporation. For transfections, 5x106 cells were resuspended in 100 µL of
Primary Rat Neuron Nucleofector Solution (Lonza) and mixed with 2 µg plasmid DNA for both
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DsRed2-Mito and SOD1 (pcDNA3.1 SOD1 WT, SOD1 K123R, SOD1 K123Q, SOD1 A4V, SOD1
A4V/K123R, or SOD1 A4V/K123Q). Neurons were electroporated using an Amaxa Nucleofector I
device (Lonza) following an optimized protocol for primary rat neurons provided by the
manufacturer.

4.2.8 Primary spinal astrocytes and transfection
Astrocytes were passaged 2-3 days before transfection and allowed to grow to about 80%
confluency. After trypsinization, a volume of cell suspension containing 3 x 10 6 cells is
transferred to a 15 mL tube and cells are pelleted by centrifugation at 100 x g for 10 minutes at
room temperature. Cells were gently resuspended in 100 µL Nucleofector solution and mixed
with 4 µg of total plasmid DNA. Cell suspensions were then transferred into electroporation
cuvettes which were placed into the holder of an Amaxa Nucleofector electroporation device
(Lonza) and run on program T-20. 500 µL of pre-warmed media was then immediately added to
each sample in their cuvettes. Samples were removed from cuvettes using sterile custom
pipettes from the Amaxa Nucleofector kit and seeded onto poly-D-lysine coated glass coverslips
at a density of 2 x 105 cells per well of a 24 well tissue culture plate containing prewarmed
astrocyte medium. Transfected astrocytes were grown in a humidified tissue culture incubator
at 37°C in 5% CO2 for 48-72 hours until processing for immunocytochemistry.
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4.2.9 Confocal microscopy
Confocal imaging was carried out with a Zeiss LSM 710 Inverted Axio Observer confocal laser
scanning microscope with six laser excitation lines (405, 458, 488, 514, 543, and 633 nm), a 34
channel QUASAR detector for spectral analysis, and several objectives including a EC PlanNeofluar 10x 0.3 numeric aperture (NA) air objective, Plan-Apochromat 20x 0.8 NA air
objective, EC Plan-Neofluar 40x 1.3 NA oil objective, and a Plan-Apochromat 63x 1.4 NA oil
objective. Image acquisition and processing were performed using Zen 2012 software from
Zeiss. To visualize Hoechst 33342, the excitation/emission wavelength was 405/495 nm using
the diode laser. For Alexa Fluor 488, the excitation/emission wavelength was 488/540 nm using
the multiline argon laser. For Alexa Fluor 594, the excitation/emission wavelength was 543/660
nm using a diode pumped solid state laser plus a QUASAR detector for all emission
wavelengths. The acquired z-stacks were maximally projected and the gamma value adjusted
using the ZEN 2012 software.

4.2.10 Live-cell imaging and quantification
Time-lapse imaging was performed using an Axiovert Zeiss 100 M inverted fluorescence
microscope equipped with a motorized focus, a Plan-Apochromat 63 × 1.4 NA oil objective, a
DG-4/Lambda 10–2 combo Xenon-arc illumination system (Sutter), a Ludl MAC
5000/bioprecision 2 linear encoded XY-motorized stage, and a Sensicam QE cooled CCD camera
(PCO AG, Germany) and controlled by MetaMorph 7.5 software (Molecular Devices). During
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imaging cells were housed in the Axiovert Incubator XL 100/135 in order to maintain a
controlled environment (37°C, humidified 5% CO2).
Cortical neurons were grown on Lab-Tek II 8-chamber slides (#1.5 German coverglass) in
neuronal medium supplemented with 2% Neuronal Supplement 21, 2 mM GlutaMAX, and and
0.25% penicillin without phenol red. To visualize the DsRed2-Mito labeled mitochondria a
S555/28x excitation filter (Chroma) and a S617/73m emission filter (Chroma) were used. 3D
images were acquired using the Multi-Dimensional Acquisition module 45 in MetaMorph 7.5.
Neurites of at least 100 μm in length were selected, and mitochondrial movement was
recorded for 5 min at 3 second intervals (6 planes, 0.5 µm step size). Kymographs were
generated by average projections of all planes without background subtraction using
MetaMorph 7.5, and the mitochondrial velocity and moving distance measurements were
exported to Microsoft Excel for further analysis.
Primary spinal astrocytes were grown on Lab-Tek II 8-chamber slides (#1.5 German coverglass)
in normal astrocyte medium without phenol red. To visualize the primary cilia and ciliary
vesicles labeled by SSTR3-EGFP, a S490/20× excitation filter (Chroma) and a S528/38m emission
filter (Chroma) were used. 3D images were acquired using the Multi-Dimensional Acquisition
module 45 in MetaMorph 7.5. Primary cilia that were well isolated with little background were
selected, and ciliary movement and budding was recorded for 90 min at 30 second intervals (11
planes, 1 µm step size). Cilia images were filtered and maximum projected using MetaMorph
7.5, and journals were utilized for image looping and the creation of movies.
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4.3 Results
4.3.1 ALS-linked SOD1 mutants demonstrate increased K123 acetylation
Protein dysfunction and accumulation into intraneuronal aggregates is observed in many
neurodegenerative disorders, including ALS. It is now also appreciated that reversible lysine
acetylation plays an important role in the pathologic misfolding of many proteins associated
with neurodegeneration. One such example is the acetylation of tau, which recent studies has
implicated in the pathogenesis of Alzheimer’s disease and other related tauopathies (Cohen et
al., 2011). For these reasons, and the fact that many SOD1 mutations cause an increased
propensity for misfolding (Prudencio and Borchelt, 2011), we sought to assess Lys123
acetylation in several mutants associated with ALS.
In order to examine the baseline Lys123 acetylation of SOD1 in human cells, we transfected
Expi293F cells with expression plasmids for wild type SOD1, the A4V, H46R, G37R, and G85R
ALS-linked SOD1 mutants, and an empty pcDNA vector as a transfection control. Based on our
previous results demonstrating an overall low level of Lys123 acetylation in SOD1 WT, we used
our custom antibody to immunoprecipitate Ac-K123 SOD1 from the lysates of transfected cells.
Immune complexes were then isolated by magnetic beads, washed, eluted, and resolved by
SDS-PAGE. Immunoblotting using a SOD1 antibody revealed that the SOD1 mutants were more
prone to Lys123 acetylation when compared to the wild type protein (Figure 31). Western blot
analysis of total SOD1 within the input lysates confirmed that the increased acetylation level
observed in the SOD1 mutants was not due to increased expression levels (Figure 31).
123

Figure 31. ALS-linked SOD1 mutants demonstrate increased K123 acetylation.
Lysates from transfected Expi293 cells were analyzed by IP-western blot with the
indicated antibodies. Total SOD1 from the input control was analyzed by western bot.
Experimental data from B. Bossy and S. Blaes, figure preparation by M. Kaliszewski.
4.3.2 Lys123 acetylation promotes mutant SOD1 misfolding
Once we discovered that ALS-linked SOD1 mutants are more likely to be acetylated at Lys123,
we wished to explore how this modification impacts SOD1 misfolding. For this analysis we
focused on the SOD1 A4V mutant, the most common mutation in North America and one
associated with rapidly progressing disease and a very high propensity to aggregate (Prudencio
et al., 2009b).
To examine if misfolded SOD1 is acetylated at Lys123, we transfected Expi1293 cells with
vectors for mammalian expression of wild type SOD1, mutant SOD1 A4V, or empty pCDNA as a
transfection control. We then performed immunoprecipitation of the lysate using the
conformation-specific C4F6 monoclonal antibody raised against misfolded SOD1. Our westernIP results confirm that misfolded mutant SOD1 is Lys123 acetylated (Figure 32A). Next, we

124

looked into how Lys123 acetylation impacts the misfolding of mutant SOD1. Based on our
previous findings demonstrating that α-TAT1 is responsible for K123 acetylation in SOD1 WT
(Figures 27-29), we compared SOD1 misfolding in transfected cells expressing either SOD1 A4V
alone or in combination with α-TAT1. Interestingly, we found that α-TAT1 overexpression
promotes mutant SOD1 misfolding (Figure 32B). The experiment was repeated with the
exception that α-TAT1 was replaced by HDAC6, the deacetylase we previously showed is
responsible for Ac-K123 SOD1 deacetylation (Figures 23-26). In accordance with the α-TAT1
results, we found that HDAC6 overexpression decreases mutant SOD1 misfolding (Figure 32C).

Figure 32. Lys123 acetylation promotes mutant SOD1 misfolding.
A. Immunopreciptation of transfected Expi293 cells using misfolded SOD1 C4F6 antibody for
pulldown and Ac-K123 SOD1 antibody for western blot. Cells were transfected with empty
pcDNA vector or expression plasmids for SOD1 WT or mutant SOD1 A4V. B.
Immunopreciptation of transfected Expi293 cells using misfolded SOD1 C4F6 antibody for
pulldown and SOD1 antibody for western blot. Cells were transfected with mutant SOD1 A4V
expression plasmid alone or in combination with α-TAT1-GFP. C. Immunopreciptation of
transfected Expi293 cells using misfolded SOD1 C4F6 antibody for pulldown and SOD1 antibody
for western blot. Cells were transfected with mutant SOD1 A4V expression plasmid alone or in
combination with HDAC6. Experimental data from B. Bossy. Figure preparation by M.
Kaliszewski.
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4.3.3 Ciliary Ac-K123 SOD1 is misfolded
Based on the association of Lys123 acetylation with both SOD1 misfolding and ciliary
localization, we next investigated whether misfolded SOD1 can be detected within primary cilia.
For this analysis primary spinal astrocytes were fixed and immunostained with antibodies
against Ac-K123 SOD1 and misfolded SOD1. Interestingly, we found that Ac-K123 SOD1 and
misfolded SOD1 are co-localized within the primary cilia of astrocytes (Figure 33).

Figure 33. Ac-K123 SOD1 and misfolded SOD1 co-localize of within the primary cilium.
Confocal micrograph (scale bar, 10 µm) of a primary astrocyte immunostained with antibodies
against Ac-K123 SOD1 and misfolded SOD1. Inset shows a 3x zoom of the boxed region
demonstrating co-localization of Ac-K123 SOD1 and misfolded SOD1 within the primary cilium.
Immunostaining and confocal microscopy by A. Kennedy, figure preparation by M. Kaliszewski.
4.3.4 Mutant SOD1 promotes primary cilia secretion
We next investigated how the expression of misfolded mutant SOD1 would affect primary cilia
structure. Primary spinal astrocytes were transfected with expression plasmids for fluorescent
protein-tagged markers of primary cilia (pEGFPN3-SSTR3 was a gift from Dr. Kirk Mykytyn, Ohio
State University College of Medicine), centrioles (dsRed-cent2 was a gift from Joseph Gleeson,
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Rockefeller University) and the nucleus (pECFP-N1-H2B was a gift from Wei Jiang, Burnham
Institute) in combination with either untagged SOD1 WT or SOD1 A4V.
The results obtained from quantification of fixed astrocytes showed a significant increase in the
ciliary budding of SOD1 A4V transfected astrocytes (Figure 34B). However, one can argue that a
drawback of this analysis is the use of static representations of cells to assess a dynamic
process. Membrane budding and vesicle release is a gradual process, and in order to identify
ciliary budding the cells and primary cilia must be fixed during the actual process (or at the
exact moment of vesicle release). Once vesicles are released into the extracellular environment
they will diffuse away from the cilia and not be captured during fixation, becoming lost in
subsequent washes during the immunostaining procedure. As a result, by limiting our analysis
to one time point (the time of cell fixation) we may not be getting a true representation of how
mutant SOD1 impacts primary cilia. This limitation may in fact undervalue the true increase of
ciliary budding in SOD1 A4V astrocytes. In addition, it can be argued that what was observed to
be ciliary budding was in fact an artifact of fixation. For these important reasons, we sought to
confirm that our findings from fixed cells were representative of ciliary membrane budding by
demonstrating the process of primary cilia-derived vesicle release in vivo.
In order to capture the process of secretion from primary cilia in living cells, we utilized timelapse fluorescent microscopy with primary spinal astrocytes that were transfected with and
expression plasmid for SOD1 A4V. In addition, the membranes of primary cilia were labeled by
co-transfection with a plasmid encoding GFP-tagged somatostatin receptor 3 (SSTR3-
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EGFP). The acquired micrographs were processed and used for creating time-lapse movies of
labeled primary cilia. These resulting movies demonstrate that primary cilia undergo membrane
budding and vesicle release. A representative time-lapse sequences of a SSTR3-EGFP labeled
primary cilium from an astrocyte expressing SOD1 A4V shows the key steps of this process
(Figure 34C). It begins with formation of a bulb-like “bouton”, followed by subapical membrane
constriction, membrane abscission, and vesicle release into the surrounding environment.
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Figure 34. Mutant SOD1 promotes the release of ciliary vesicles from astrocytes.
A. Fluorescent micrograph (scale bar, 10 µm) of astrocytes transfected with expression vectors
for SSTR3-EGFP, DsRed Cent2, and Histone 2B-CFP in combination with either SOD1 WT or
SOD1 A4V. B. Quantification of ciliary budding in fixed astrocytes transfected with expression
plasmids for SOD1 WT, SOD1 A4V, or pcDNA3 empty vector control. Data is shown with
standard error of the mean error bars from three independent experiments (significance at
P<0.01 by ANOVA). C. Time-lapse sequence of a primary cilium (identified with SSTR3-GFP) of
an SOD1 A4V expressing astrocyte undergoing the distinct stages of bouton formation,
membrane constriction, abscission, and vesicle release. Fluorescent microscopy and time-lapse
imaging by A. Kennedy, quantification by A. Kennedy and K. Kleinschmidt, and figure
preparation by M. Kaliszewski.
4.3.5 Ac-K123 SOD1 is found in primary cilia derived vesicles
After demonstrating that mutant SOD1 expression in astrocytes increased the secretion of
vesicles from primary cilia, we next looked to investigate the contents of these vesicles. Based
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on our astrocyte immunostaining data that demonstrates the SOD1 localized to the primary
cilium is both Lys123 acetylated and misfolded, we were curious to see if Ac-K123 SOD1 can be
found within primary cilia-derived vesicles. Having already shown that Lys123 acetylation
promoted SOD1 misfolding, if Ac-K123 SOD1 is in fact secreted within these vesicles then
primary cilia may represent a novel source for the cellular release of misfolded SOD1. And
based on reports describing the fusion and reuptake of ciliary vesicles at distant cells, the
primary cilia may represent a previously unknown conduit for the transfer of misfolded SOD1
between cells.
In order to assess whether Ac-K123 SOD1 can be found within budding ciliary vesicles, we first
transfected primary astrocytes with expression plasmids for fluorescently-tagged markers of
nucleus and primary cilia. After 3 days cells were fixed and immunostained for Ac-K123 SOD1.
Our results show that Ac-K123 SOD1 is found within primary cilia undergoing membrane
budding and vesicle release (Figure 35A).
To demonstrate that Ac-K123 SOD1 is localized within actual secreted vesicles, we analyzed the
contents vesicles isolated from the conditioned medium of astrocytes transfected with the
SSTR3-EGFP marker in combination with either SOD1 WT or SOD1 A4V. Western blot analysis
showed that both Ac-K123 SOD1 and GFP, the fluorescent tag fused to the ciliary membrane
protein SSTR3, are present within the isolated vesicles (Figure 35B). In addition, the detection of
Ac-K123 SOD1 detection was higher in vesicles isolated from the conditioned medium of SOD1
A4V transfected astrocytes (Figure 35B). This hints at a defensive mechanism for the removal of
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misfolded SOD1 from the primary cilia, possibly as a preventive measure to safeguard
microtubule-dependent ciliary function from mutant SOD1-mediated impairment. Taken
together, these findings demonstrate that Ac-K123 SOD1 is both localized to primary cilia
undergoing membrane budding and is found within secreted vesicles derived from the ciliary
membrane.

Figure 35. Ac-K123 SOD1 is found in primary cilia derived vesicles.
A. Fluorescent micrograph (scale bar, 2 µm) of a SSTR3-EGFP and histone 2B-CFP transfected
primary astrocyte immunostained for Ac-K123 SOD1. Inset shows region of the primary cilium
with the SSTR3-GFP channel disabled. Imaging performed by A. Kennedy. B. Western blot of
vesicles isolated from astrocyte conditioned medium and probed for Ac-K123 SOD1 and GFP
(tag for SSTR3). Western blot analysis by R. Shaffer.
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4.3.6 Ac-K123 SOD1 in choroid plexus and ependymal cells of ventricle and central canal
A hallmark feature of ALS is the focality of clinical onset and regional spreading of symptoms. A
popular theory explaining the spreading of ALS along the motor nervous system involves the
prion-like propagation of misfolded SOD1, although the exact mechanism of misfolded SOD1
cell-to-cell transfer is not fully understood. Interestingly, SOD1 has been detected in human
cerebral spinal fluid (CSF) samples (Winer L et al., 2013). A recent hypothesis suggests that the
CSF might be involved in the regional spreading of ALS (Smith et al., 2015). Thus, we sought to
explore whether Ac-K123 SOD1 was present in regions of the brain in contact with CSF.
Our findings show that Ac-K123 SOD1 was found within the choroid plexus and in ependymal
cells lining the ventricles (section 2.3.5, Figure 8). Interestingly, Ac-K123 SOD1 was localized
within motile cilia of ependymal cells, as demonstrated by co-labeling of these structures for
Ac-K123 SOD1 and the ciliary marker Ac-K40 α-Tubulin (Figure 36A). Because the 4th ventricle
narrows caudally to eventually empty into the spinal cord, we next analyzed immunostained
transverse spinal cord cryosections to assess Ac-K123 SOD1 distribution. Weak staining was
noted in cell bodies throughout the white and gray matter, but the most prominent staining
was observed in ependymal cells lining the central canal (Figure 36B), the CSF-filled space that
is continuous with the ventricular system of the brain.
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Figure 36. Ac-K123 SOD1 localization in choroid plexus and ependymal cells.
A. Sagittal view confocal micrograph (scale bar, 10 µm) of 4th ventricle wall immunostained for
Ac-K123 SOD1 (R26) and Ac-K40 α-Tubulin. Nuclei were counterstained with Hoechst 33342.
Cilia of the ependymal cells are labeled (arrow). Inset shows a 2x zoom of the boxed region
demonstrating Ac-K123 SOD1 and Ac-K40 α-Tubulin co-labeling within the cilia. Tissue
embedding and cryosectioning by S. Blaes. B. Confocal micrograph (scale bar, 50 µm) of a
transverse section of spinal cord immunostained for Ac-K123 SOD1 (R26). On the left is a
schematic of a transverse spinal cord section demonstrating the location of the central canal.
4.3.7 Acetyl mimetic SOD1 K123Q impairs axonal transport
Several previous studies have demonstrated defective axonal trafficking in ALS mouse models,
stemming from the interaction between mutant SOD1 and motor proteins (De Vos et al., 2007;
Warita et al., 1999; Williamson and Cleveland, 1999). Based on our observations that Ac-K123
SOD1 misfolds (similar to mutant SOD1) and is localized along axonal processes, we next
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investigated if SOD1 acetylation impacts axonal transport in neurons. Primary cortical neurons
were transfected with DsRed2-Mito, a mammalian expression vector that encodes red
fluorescent protein fused to a mitochondrial targeting sequence, in combination with
expression vectors for SOD1 WT, SOD1 K123R, or SOD1 K123Q. DsRed2-Mito was used for
fluorescent labeling of mitochondria and allowed us to observe axonal transport of
mitochondria in living cells. Fast acquisition fluorescence time-lapse imaging was used to
measure mitochondrial movement over a period of 5 minutes.
Representative kymographs of cortical neurons expressing either SOD1 WT or SOD1 K123R
show both vertical and horizontal lines, indicating mitochondria mobility and movement in both
the anterograde and retrograde directions (Figure 37A, top and middle panels). By contrast, a
kymograph for neurons expressing SOD1 K123Q displayed mostly vertical lines, indicating
minimal movement of mitochondria and reduced axonal transport (Figure 37A, bottom
panel). Quantitative analysis indicated a significant reduction in the velocity of mitochondrial
transport in SOD1 K123Q neurons when compared to SOD1 WT and SOD1 K123R neurons
(Figure 37B). Moreover, the mitochondrial mobility of SOD1 K123Q neurons was decreased by
more than 80% (Figure 37C). These results demonstrate that SOD1 Lys123 acetylation,
represented by acetyl-mimetic SOD1 K123Q, triggers mitochondrial axonal transport defects in
cultured neurons.
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Figure 37. Lys123 acetylated SOD1 impairs axonal transport of mitochondria in cortical neurons.
A. Kymographs of cortical neurons expressing DsRed2-Mito and either SOD1 WT, SOD1
K123R, or SOD1K123Q. B. Mean velocity of mitochondria in the axons of cortical neurons
expressing DsRed2-Mito and either SOD1 WT, SOD1 K123R, or SOD1K123Q. D) Mitochondrial
mobility in cortical neurons expressing DsRed2-Mito and either SOD1 WT, SOD1 K123R, or
SOD1K123Q. P value: ANOVA, n = 10. Live cell imaging by A. Kennedy. Kymographs processing,
quantification, and analysis by M. Kaliszewski.
4.3.8 K123R mutation rescues SOD1 A4V from axonal transport defects
Based on our finding showing that SOD1 WT acetylation impaired axonal transport, we sought
to test whether blocking Lys123 acetylation could rescue mutant SOD1-induced trafficking
defects. To test this hypothesis we created mutant SOD1 Lys123 deacetylated and acetyl135

mimetics by cloning K123R and K123Q mutations into an expression vector for SOD1 A4V. We
then co-transfected cortical neurons with SOD1 A4V, SOD1 A4V/K123R or SOD1 A4V/K123Q in
combination with DsRed2-Mito. Neurons expressing the constitutively acetylated mutant SOD1
A4V/K123Q exhibited mitochondrial transport defects typical for mutant SOD1 A4V (Figure 38A,
top and middle panels). Remarkably, mitochondrial transport was restored in the acetylation
resistant SOD1 A4V/K123R neurons (Figure 38A, bottom panel). In addition, mitochondrial
velocity and motility were rescued in neurons expressing the SOD1 A4V/K123R mutant (Figure
38B-C). This data collectively shows that mitochondrial transport, mean velocity, and overall
mobility are regained by inhibiting Lys123 acetylation of mutant SOD1. Therefore, Lys123
acetylation explain the axonal transport defects observed in mutant SOD1 neurons.
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Figure 38. Mutant SOD1 Lys123 deacetylation rescues neurons from mitochondrial trafficking
defects.
A. Kymographs of cortical neurons expressing DsRed2-Mito and either SOD1 A4V, SOD1
A4V/K123Q, or SOD1 A4V/K123R. B. Mean velocity of mitochondria in the axons of cortical
neurons expressing DsRed2-Mito and either SOD1 A4V, SOD1 A4V/K123Q, or SOD1 A4V/K123R.
D) Mitochondrial mobility in cortical neurons expressing DsRed2-Mito and either SOD1 A4V,
SOD1 A4V/K123Q, or SOD1 A4V/K123R. P value: ANOVA, n = 10. Live cell imaging by A.
Kennedy. Kymographs processing, quantification, and analysis by M. Kaliszewski.

4.4 Discussion
Mutations of the SOD1 gene are toxic to motor neurons and represent the first identified
genetic component linked to the subset of rare inherited ALS cases (Rosen et al., 1993). Since
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the identification of the first mutation in 1993, more than 180 mutations have been described
in SOD1. Murine models based on mutant SOD1 expression develop ALS-like disease and have
provided many mechanistic details with regards to mutant SOD1-mediated toxicity. Samples
from patients with SOD1 mutations and mutant SOD1 mice exhibit cytoplasmic inclusions
containing SOD1 (Kato, 2007), indicating a role for SOD1 misfolding in ALS. Clinically, both SALS
and FALS are very similar, suggesting a common downstream pathogenic mechanism. Recent
evidence reports that SOD1 modification is implicated in the sporadic form of the disease
(Bosco et al., 2010). For these reasons we investigated the impact of SOD1 acetylation at
Lys123. This residue has been previously reported to be modified by acetylation (Choudhary et
al., 2009; Zhao et al., 2010), and is located within the electrostatic loop, an important functional
domain responsible for substrate recruitment to the active site. This investigation also
expanded on our previous findings describing the regulation of SOD1 Lys123 acetylation by
HDAC6 and α-TAT1 and the localization of Ac-K123 SOD1 to the primary cilium.
We showed that many ALS-linked SOD1 mutants exhibit increased Lys123 acetylation (Section
4.3.1, figure 31), and explored the impact that this modification may have with regards to ALS
pathogenesis. Because the gain-of-function toxicity associated with mutant SOD1 often stems
from conformational changes and misfolding, we assessed the relationship between Lys123
acetylation and misfolding. Interestingly, we found that Lys123 acetylation increased mutant
SOD1 misfolding in a HDAC6 and α-TAT1-dependent manner. This is the first evidence showing
acetylation promote SOD1 misfolding, and it is supported by findings that have demonstrated
aberrant conformations of wild type SOD1 resulting from by oxidation, metal loss, and other
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altered post-translational modifications (Bosco et al., 2010; Ezzi et al., 2007; Guareschi et al.,
2012). It is important to note that we also showed α-TAT1 and HDAC directly interact with
SOD1 and modify Lys123 through acetylation and deacetylation. However, it is possible that the
altered detection of misfolded SOD1 is a result of secondary events not related to these
proteins directly interacting with SOD1. For instance, in addition to being a deacetylase HDAC6
also possesses an ubiquitin-binding domain and is responsible for the disposal of misfolded
protein aggregates (Kawaguchi et al., 2003). It is therefore possible that although we have
shown HDAC6 deacetylates SOD1, the decline in misfolded SOD1 accompanying HDAC6
expression is simply a result of clearance via the lysosome-dependent degradative system. In
this regard, contrary reports have been published concerning the role of HDAC6 in ALS
pathogenesis. For example, in a cellular model study using live cell imaging and cellulose
acetate membrane filtration HDAC6 knockdown was shown to increase mutant SOD1
aggregation (Gal et al., 2013), while in an animal model study Hdac6 deletion was found to
significantly extend the survival of SOD1 G93A mice (Taes et al., 2013). Based on the
controversial role of HDAC6 in ALS, further studies examining the Lys123 acetylation and SOD1
misfolding is required. One such experimental modification would be to compare the detection
of misfolded SOD1 in astrocytes when mutant SOD1 is expressed in combination with either
wild type HDAC6, an HDAC6 mutant with a deleted ubiquitin-binding domain, or an HDAC6
mutant with deleted deacetylase domains. Results from such a study may guide us to a better
understanding of the relationship between HDAC6, Lys123 acetylation, and SOD1 misfolding.
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In addition to an expanded inquiry of HDAC6-mediated Lys123 deacetylation and SOD1
misfolding, a more in-depth analysis of the structural changes associated with Lys123
acetylation can also provide more insight into how this modification promotes misfolding of
SOD1. The location of Lys123 within the electrostatic loop is of significance, as structural
change and perturbation of the electrostatic loop are a common property of several FALSassociated SOD1 variants (Molnar et al., 2009). When this is considered in the context of Lys123
acetylation and SOD1 misfolding, there is an important question of causation versus
correlation. Does Lys123 acetylation promote the conformational changes that alter
electrostatic loop structure and lead to misfolding, or are SOD1 mutants simply more prone to
acetylation due to an increased Lys123 accessibility to acetyl-transferases resulting from
increased electrostatic loop dynamics? A spectroscopic structural analysis, such as circular
dichroism, of SOD1 Lys123 acetylated mimetics and constitutively deacetylated mimetics may
shed light on how acetylation affects SOD1 deacetylation and should be examined in in both
wild type and ALS-linked mutant proteins. Based on previous studies that indicate electrostatic
loop structural changes lead to intermolecular interactions and fibril formation, results from CD
analysis of SOD1 Lys123 acetylation may provide a mechanism for SOD1 aggregation (Elam et
al., 2003).
Based on our findings showing increased Lys123 acetylation in several ALS-linked SOD1 mutants
(Section 4.3.1, figure 31), we explored how mutant SOD1 Lys123 acetylation impacts
microtubule-based transport. Previous studies from our lab and other groups report axonal
transport defects resulting from mutant SOD1 expression in neurons (De Vos et al., 2007; Song
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et al., 2013; Warita et al., 1999; Williamson and Cleveland, 1999), and in this study we
demonstrated that removal of Lys123 acetylation abolished the transport defects associated
with mutant SOD1. It remains to be determined how mutant SOD1 Lys123 acetylation
mechanistically impacts axonal transport. A common effect of protein acetylation is altered
protein-protein interactions, and it is possible that Lys123 acetylation promotes mutant SOD1
interaction with the microtubule motor protein complex.
Another key finding was the localization of both misfolded and Lys123 acetylated SOD1 within
the primary cilium. Previous studies have shown a decreased primary cilia number in G93A mice
spinal cord primary culture and in situ (Ma et al., 2011), and mutant SOD1 overexpression was
shown to decrease primary cilia-mediated Shh pathway signaling and render cells more
susceptible to oxidative stress (Peterson and Turnbull, 2011). Treatment with Shh or Shh
agonists proved to be cytoprotective to mutant SOD1 cells, further suggesting that defective
primary cilia-mediated signaling may play a role in ALS. Based on these findings and the fact
that primary cilia signaling is dependent on transport along the axoneme (Liem et al., 2012), we
explored how mutant SOD1 Lys123 acetylation impacts microtubule-based transport. Previous
studies from our lab and other groups reported axonal transport defects resulting from mutant
SOD1 expression in neurons, and in this study we demonstrated that removal of Lys123
acetylation abolished the transport defects associated with mutant SOD1. When considered in
the context of decreased Shh signaling mediated by mutant SOD1, the direct impact of mutant
SOD1 Lys123 acetylation on primary cilia signaling merits further consideration. For these
reasons, a study on the impact of SOD1 Lys123 acetylation on the function of microtubule141

based primary cilia is merited and has the potential to elucidate the mechanism behind the Shh
signaling impairment observed in ALS models. Because the downstream effect of Shh signaling
transduction is the activation of Gli transcription factors (Briscoe and Thérond, 2013), a simple
study employing a Gli reporter assay (many Luciferase-based kits are commercially available)
and astrocytes expressing either wild type SOD1, ALS-linked mutants, or the Lys123 acetylated
and deacetylated mimetics of wild type and mutant SOD1 can be performed. These results can
subsequently identify any disruptions to Shh signaling due to SOD1 Lys123 acetylation.
Furthermore, we have shown that expression of the acetyl-mimetic SOD1 K123Q impaired
axonal transport in cortical neurons. These findings demonstrate that Lys123 acetylation of wild
type SOD1 causes mutant SOD1-like microtubule-based transport impairments, providing a
possible molecular mechanism that underlies both rare FALS and the more common SALS.
We also demonstrated that mutant SOD1 expression causes aberrant primary cilia morphology
and promotes secretion of ciliary vesicles containing Ac-K123 SOD1. Considering that ALS is
characterized by prion-like spreading of toxic misfolded proteins, our data indicate primary
cilia-derived vesicles as a possible conduit for the intercellular transfer of misfolded SOD1 and
further study is of high importance.
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CHAPTER FIVE: DISCUSSION
The aim of this study was to examine SOD1 Lys123 acetylation within the central nervous
system (on a regional, cellular level and eventually subcellular level) and determine if this
modification has any implication in disease. In the course of this work, affinity-purified rabbit
polyclonal antibodies were generated and validated as specific against Lys123 acetylated SOD1.
The acetylated synthetic peptides used for immunization were based on the documented SOD1
acetylation site at Lys123 identified through mass spectrometry during previous highthroughput proteomic studies.
We used immunohistochemistry to assess Ac-K123 SOD1 distribution in the normal nervous
system. Ac-K123 SOD1 was detected within distinct regions and cell types, and one
commonality of the observed immunostaining was the prominent labeling in glutamatergic
neurons within the cerebellar cortex, dentate gyrus, hippocampus, olfactory bulb, and retina. In
the ventricular system, choroid plexus cuboidal cells and ependymal cells of the ventricle wall
and spinal cord central canal also exhibited strong staining. This initial study demonstrated that
SOD1 acetylation is confined to specific regions and cells, especially when considering that
SOD1 is so abundant and ubiquitously expressed throughout the central nervous system(Pardo
et al., 1995). However, in order to appreciate the relevance of these immunohistochemical
findings it is pertinent to follow up this study with an examination of Ac-K123 SOD1 distribution
in the nervous system of mouse models for disease or aging. It would be especially valuable to
determine if there is any alteration in Ac-K123 SOD1 levels within the motor cortex, bulbar
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region, or spinal cord of mutant SOD1 mice. Aside from the central canal of the spinal there was
not significant labeling in these areas, so it would be interesting to see if Ac-K123 SOD1 is
increased in mutant SOD1 mice.
Ac-K123 SOD1 antibody immunostaining of primary astrocyte and neuronal cultures
demonstrated a distinct subcellular localization of SOD1 Lys123 acetylation. In contrast to the
predominantly cytoplasmic localization of SOD1, Ac-K123 SOD1 was found within neuronal
nuclei and neurites and in nuclei and primary cilia of astrocytes. The localization of Ac-K123
SOD1 within astrocytes was also cell cycle dependent, with nuclear localization strongest during
G1 and G2 phases of interphase and weakest during cell cycle arrest. SOD1 has been shown to
translocate to the nucleus and act as a transcription factor during cellular exposure to oxidative
stress, but this function does not explain the nuclear localization of Ac-K123 SOD1 during G1
and G2. Further studies will be also required to elucidate the role of Lys123 acetylation with
regards to SOD1 translocation and retention within the nucleus and primary cilia of astrocytes.
The association of Ac-K123 SOD1 with chromosomes during metaphase and anaphase was also
an interesting find, as diffusion into the rest of the cell would be expected after the break of the
nuclear envelope. It is possible that acetylation supports directly maintains SOD1 interaction
with chromosomes in order to allow close proximity and defense against DNA oxidative
damage. There is also the possibility that extended nuclear localization of SOD1 can be
detrimental to the genomic integrity of the cell. K123 acetylation may promote perturbation of
the electrostatic loop, allowing non-specific substrates to enter the active site. This can result in
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aberrant copper redox chemistry, and in the cellular environment this may cause reverse
catalysis with the production of superoxide.
The localization within the primary cilium was an exciting discovery that was further explored.
Using a candidate approach based on ciliary localization, we tested and confirmed that HDAC6
deacetylases Ac-K123 SOD1 and α-TAT1 acetylates SOD1 at Lys123. It should be noted that
although we were able to provide evidence of the enzymes modifying Lys123 acetylation, we
cannot exclude the possibility there are other regulators of SOD1 acetylation. Based on the
reported implications of wild type SOD1 modification promoting misfolding, we investigated
the relationship between SOD1 misfolding and Lys123 acetylation. We found that ALS-linked
SOD1 mutants exhibit increased Lys123 acetylation and this misfolding was responsive to
increased expression of HDAC6 or α-TAT1. In addition to acetylation, SOD1 Lys123 is also
subject to other modifications such as ubiquitination (Wagner et al., 2011; Wu et al., 2015). In
this regard, K123 acetylation may compete with ubiquitination and act as a means of delaying
protein degradation. The increased K123 acetylation of ALS-linked mutants may prevent their
degradation, thereby increasing their half-life. If this is the case, further studies into the impact
of K123 acetylation on SOD1 stability and resistance to degradation is highly warranted.
Interestingly, we also found that SOD1 within the primary cilium is both Lys123 acetylated and
misfolded through co-immunostaining with a conformation specific antibody against misfolded
SOD1. The localization of misfolded SOD1 within the primary cilia was unexpected, and it is yet
to be determined if this compartmentalization of misfolded SOD1 serves a physiologic role for
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the cell. It is possible that this is a protective mechanism to isolate misfolded SOD1 from the
rest of the cell. Interestingly, in addition to their role of signaling to the cell body, primary cilia
are also secretory organelles that communicate with other cells. Due to the localization of
misfolded SOD1, the primary cilia may represent a source of SOD1 aggregation seeds that can
undergo intercellular transfer via ciliary membrane-bound vesicles. Importantly, mutant SOD1
expression increased primary cilia membrane budding in astrocytes and the detection of AcK123 SOD1 isolated from vesicles in conditioned medium. Based on these findings we have
developed a model implicating Lys123 acetylation in the prion-like transfer of misfolded SOD1
(Figure 39). This model is also supported by the non-cell autonomous nature of ALS, as we
speculate that ciliary-derived vesicles from astrocytes are the conduit for transferring Lys123
acetylated and misfolded SOD1 to motor neurons. Based on our findings in cortical neurons, we
predict that acetylated SOD1 will also impair axonal transport within motor neurons.
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Figure 39. Current model for promotion of SOD1 misfolding and cell-to-cell transfer by K123
acetylation.
SOD1 Lys123 acetylation by α-TAT1 promotes monomerization and subsequent protein
misfolding. Ac-K123 SOD1 localization has been observed within primary cilia of astrocytes and
primary cilia-derived vesicles. These vesicles containing Ac-K123 SOD1 can be taken up by
neurons. Within neurons, Ac-K123 SOD1 impairs axonal transport in a fashion similar to
misfolded mutant SOD1.

Although we have described the relationship SOD1 Lys123 acetylation and misfolding,
additional evidence beyond that derived from the use of a conformation-specific antibody will
be needed. Data from structural studies, such as circular dichroism, and analysis of human
samples (healthy versus ALS) with Ac-K123 SOD1 antibody will aid in supporting the notion that
Lys123 acetylation promotes SOD1 misfolding. The other components of prion-like transfer
that need to be addressed are the ability of Ac-K123 SOD1 to seed misfolding and aggregation
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of natively folded SOD1, and confirmation that Ac-K123 SOD1 within primary cilia-derived
vesicles is misfolded and taken up by neighboring cells.
Interestingly, results from a recent whole-exome screening study reported that variants of
NEK1, a protein linked to microtubule stability and cilia formation, confers susceptibility to
amyotrophic lateral sclerosis (Kenna et al., 2016). This data further supports a possible role for
primary cilia in ALS pathogenesis, and it will be of interest to investigate how Lys123 acetylation
impacts SOD1 interaction with NEK1.
This work examines the impact of Lys123 acetylation on SOD1 structure and localization, with
the hope that a better understanding of these relationships will help to further elucidate the
etiology of familial and sporadic ALS. This study also lays the groundwork for future studies
investigating the intercellular transfer of misfolded SOD1 via primary cilia-derived vesicles. The
antibodies developed during the course of this work have the potential to provide valuable
tools for evaluating disease progression by assessing aberrant SOD1 acetylation through
immunohistochemical analysis of tissue from animal models or post-mortem samples.
Acetylated SOD1 also has the potential to be utilized as a biomarker ALS, possibly through
detection within patient CSF samples.
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Ownership of copyright in the article "Primary cilia and autophagic dysfunction in Huntington’s
disease" published in Cell Death and Differentiation remains with the authors. Thus, the figures
which have been published are allowed to be reproduced in this dissertation.
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Adaption and reuse of figures from the article "SOD1 Lysine 123 Acetylation in the Adult Central
Nervous System” published in Frontiers in Cellular Neuroscience is permitted provided that
authors and original source are appropriately accredited. Thus, the figures which have been
published are allowed to be reproduced in this dissertation.
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